Biological response to surface modified magnesium alloys-based biodegradable implants by Mónica Pereira Garcia
  
Faculdade de Engenharia da Universidade do Porto 
 
 
 
 
Biological response to surface modified magnesium alloys-
based biodegradable implants 
 
 
 
 
Mónica Pereira Garcia 
 
 
 
Dissertação submetida para satisfação parcial dos requisitos do 
grau de Doutor em Engenharia Biomédica 
 
 
Porto, 2015
ii 
 
Thesis prepared under the supervision of: 
 
Professora Maria Helena Fernandes (Supervisor) 
Faculdade de Medicina Dentária da Universidade do Porto 
 
Maria de Fátima Grilo da Costa Montemor (Co-supervisor) 
Instituto Superior Técnico, Universidade de Lisboa 
 
 
The experimental work described in this thesis was conducted at: 
Laboratory for Bone Metabolism and Regeneration, 
Faculdade de Medicina Dentária da Universidade do Porto 
 
Base materials, anodised and polymeric-coatings were prepared at Instituto Superior 
Técnico da Universidade de Lisboa (IST), The Institute of Precision Mechanics (IPM) 
of the Faculty of Materials Science & Engineering, Warsaw University of Technology 
and the Materials Engineers Group sp. z o.o. (MEG), a spin-off company of the Faculty 
of Materials Science & Engineering, Warsaw University of Technology. 
 
 
The research described in this thesis was performed within the project: 
“A new generation of biodegradable implants obtained from magnesium alloys 
functionalized by means of advanced surface treatment”; European Micro and Nano 
Technology Network, FP7 - ERAMNT/0002/2009 
  
iii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
À  minha  família 
 
 
 
 
  
iv 
 
Abstract 
 
 
 
In recent years, a new generation of biodegradable metallic materials, magnesium 
(Mg) alloys, gained more attention for bone tissue applications. Mg alloys present a set 
of properties suitable for bone tissue regeneration, especially the similar mechanical 
characteristics. The main limitation for the of Mg alloys for these applications is the fast 
degradation rate in physiological environment. Many attempts have been proposed in 
literature to improve the lifetime of Mg implants by controlling its degradation rate, 
with various results. 
The aim of this work was to characterize the cytocompatibility of an innovative 
surface multifunctionalisation technology for Mg alloys in order to use these materials 
as biodegradable implants in orthopaedic applications. 
A series of surfaces were analysed for their biocompatibility in this work: (i) bare 
AZ31, AZ61 and RZ5 Mg alloys, (ii) anodised AZ31 and RZ5 Mg alloys, and (iii) 
polymeric-based coatings applied on bare and anodised Mg AZ31 alloy. Two polymeric 
coatings were used, namely based on polyether imide (PEI) and polycaprolactone (PCL) 
as base material; the coatings were used alone and, also, containing different 
concentrations of nanohydroxyapatite particles (HA). 
Direct and indirect assays were used in the cytocompatibility testing. In the direct 
assay, cells were cultured on the materials’ surface, and, in the indirect assay, cells were 
cultured in the presence of extracts from the Mg-based substrates. In the direct assays, 
MG-63 osteoblastic cells were used as the cell culture model. In the indirect assays, cell 
response was assessed for human mesenchymal stem cells, human osteoclastic cells and 
human endothelial cells. Cell behaviour was analysed for cell viability/proliferation and 
specific phenotype parameters. 
MG-63 cells cultured on the surface of naked Mg alloys showed a decrease in 
viability/proliferation, especially AZ61 alloy. These results were associated with a 
higher corrosion rate in AZ61, creating a dynamic surface unsuitable for cell attachment 
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and proliferation. Comparatively, the anodised alloys showed an increase in 
viability/proliferation, evidencing a better surface and environment for cell attachment 
and further growth. Regarding the cell response over the polymeric coatings, firstly, one 
experiment was performed in which the coating was applied to glass coverslips in order 
to analyse the biocompatibility of the various coating compositions, without the 
influence of the Mg alloy. Both coatings presented an improved biological performance 
compared to the bare and the anodised alloy. Additionally, a better cell response was 
observed for the polymeric coatings containing HA particles, with a significant increase 
in viability/proliferation and functional activity. A similar behaviour was found on the 
coatings applied to Mg alloys, compared to uncoated samples. 
In the indirect assays, cell response was evaluated in the presence of extracts from 
the Mg-based materials AZ31 alloy, anodised AZ31 alloy and anodised AZ31 alloy 
coated with the polymeric coating PEI containing 2% HA. The extract was added to 
cultures of human mesenchymal stem cells (HMSC), human peripheral blood 
mononuclear cells (PBMC) and human umbilical vein endothelial cells (HUVEC). Cell 
response to the extracts from AZ31 alloy and anodised AZ31 alloy was concentration 
and cell-dependent. At high concentrations, the extracts were found to be cytotoxic for 
all tested cells. However, at low concentrations, the extracts elicited positive effects, 
increasing cell proliferation and functional activity. The extracts from anodised AZ31 
alloy coated with PEI containing 2%HA did not cause significant effects on the cell 
behaviour on the tested concentration range. 
To evaluate the contribution of Mg ion in the cellular response, a range of Mg 
concentrations was tested in osteoblastic, osteoclastic and endothelial cell cultures. The 
results showed a dose-dependent effect. At high concentrations, Mg ion caused an 
inhibitory effect in all cell types. In low concentrations no significant effects were 
observed in osteoblastic and endothelial cells, however in osteoclastic cell cultures, an 
increase in DNA content and TRAP activity was noticed. 
In conclusion, Mg alloys showed promising characteristics for bone tissue 
applications. Surface treatments of the alloy, by anodisation and polymeric-based 
coatings, increased the cytocompatibility of the Mg alloys. The multifunctionalization 
approach of the Mg alloys proposed in this study appears to be a promising strategy to 
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obtain biologically safe and active biodegradable Mg-based materials for bone tissue 
applications. 
 
Key words: Magnesium alloys, anodisation, polymeric coatings, cytocompatibility, 
human mesenchymal stem cells, osteoclastic cells, endothelial cells 
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Resumo 
 
 
 
As ligas de magnésio (Mg), uma nova geração de materiais metálicos 
biodegradáveis, têm vindo a evidenciar grande interesse para aplicações no tecido 
ósseo. As ligas de magnésio apresentam um conjunto de propriedades apropriadas para 
a regeneração do tecido ósseo. A maior limitação das ligas de Mg é a sua rápida taxa de 
degradação em ambiente fisiológico. Várias técnicas têm sido propostas para melhorar o 
tempo de vida dos implantes de Mg controlando a sua degradação, com variadas taxas 
de sucesso. 
Este trabalho teve como objectivo a caracterização da citocompatibilidade de uma 
tecnologia de multifuncionalização de superfície para ligas de Mg, de forma a utilizar 
estes materiais como implantes biodegradáveis em aplicações ortopédicas. 
O trabalho experimental incluiu a avaliação da citocompatibilidade de uma série de 
superfícies: (i) as ligas base AZ31, AZ61 e RZ5, (ii) as ligas AZ31 e RZ5 anodizadas e 
(iii) revestimentos poliméricos aplicados na liga base a anodisada AZ31. Foram 
utilizados dois revestimentos poliméricos, baseados em poliéster imida (PEI) e 
policaprolactona (PCL) como material base, em que algumas das composições 
continham diferentes concentrações de partículas de nanohidroxiapatite (HA). 
A avaliação da citocompatibilidade incluiu ensaios directos e indirectos. Nos ensaios 
directos, as células foram cultivadas na superfície dos materiais, e nos ensaios 
indirectos, as células foram cultivadas na presença de extractos obtidos dos substratos 
de Mg. Nos testes directos, as culturas de células osteoblásticas MG-63 foram usadas 
como modelo de estudo. Nos testes indirectos, a resposta celular foi avaliada para 
células pluripotentes mesenquimais humanas, células osteoclásticas humanas e células 
endoteliais humanas. O comportamento celular foi avaliado para a 
viabilidade/proliferação celular e parâmetros fenotípicos específicos. 
As células MG-63 cultivadas na superfície das ligas base de Mg apresentaram um 
decréscimo na viabilidade/proliferação, principalmente a liga AZ61. Estes resultados 
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foram associados com uma maior taxa de corrosão nesta liga, que origina uma 
superfície dinâmica inadequada para a adesão e proliferação celular. Comparativamente, 
as ligas anodizadas exibiram um aumento na viabilidade/proliferação, evidenciando 
uma melhor superfície e ambiente para a adesão e crescimento celular. Relativamente à 
resposta celular nos revestimentos poliméricos, inicialmente, o revestimento foi 
aplicado em lamelas de vidro de forma a analisar a citocompatibilidade de diversas 
composições, sem a influência da liga de Mg. Os revestimentos poliméricos 
apresentaram melhor desempenho biológico que a liga base ou anodizada. Em ambos, 
observou-se uma melhor resposta celular nos revestimentos com partículas de HA na 
sua composição, com um aumento significativo na viabilidade /proliferação e actividade 
funcional. Nos revestimentos aplicados na liga de Mg verificou-se um comportamento 
semelhante, comparando com as amostras base.  
Nos ensaios indirectos, a resposta celular foi avaliada na presença de extractos da 
liga AZ31, liga AZ31 anodizada e liga AZ31 anodizada revestida com PEI contendo 2% 
de HA. Os extractos foram adicionados a culturas de células estaminais mesenquimais 
humanas (hMSC), células mononucleares humanas do sangue periférico (PBMC) e 
células endoteliais humanas da veia umbilical (HUVEC). A resposta celular aos 
extractos da liga AZ31 e liga anodizada revelou ser dependente da concentração e tipo 
celular. Em concentrações elevadas, os extractos mostraram ser citotóxicos para todas 
as células testadas. No entanto, em concentrações baixas, os extractos causaram efeitos 
positivos, aumentando a proliferação celular e actividade funcional. Os extractos 
provenientes da liga AZ31 anodizada com revestimento polimérico não causaram 
efeitos significativos no comportamento celular, na gama de concentrações testada. 
De forma a avaliar a contribuição do ião Mg na resposta celular, uma gama de 
concentrações de Mg foi testada em culturas celulares osteoblásticas, osteoclásticas e 
endoteliais. Os resultados mostraram um efeito dependente da dose. Concentrações 
elevadas do ião Mg mostraram ter um efeito inibitório em todas as culturas celulares. 
Em concentrações mais baixas não foram observados efeitos significativos nas culturas 
osteoblásticas e endoteliais, no entanto, nas culturas osteoclásticas, observou-se um 
aumento na concentração do DNA e na actividade da TRAP.  
Em conclusão, as ligas de Mg demonstraram possuir características promissoras 
para aplicações no tecido ósseo. Os tratamentos de superfície das ligas, por anodização 
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e revestimentos poliméricos, aumentaram a citocompatibilidade das ligas de Mg. Os 
resultados evidenciam que os revestimentos poliméricos são uma estratégia promissora 
para a obtenção de implantes de Mg biologicamente seguros e activos para aplicações 
ortopédicas. 
 
Palavras-chave: ligas de magnésio, anodização, revestimento polimérico, 
citocompatibilidade, células pluripotentes mesenquimais humanas, células 
osteoclásticas, células endoteliais  
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Chapter 1 
Motivation, objectives and structure of the thesis 
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In recent years, magnesium (Mg) and its alloys have gain attention for biomedical 
applications owning to a set of characteristics especially suitable for orthopaedics 
applications. To begin with, it is an important cation in the human body, predominantly 
present in bone tissue [1,2]. Mg has several important roles in the cells, such as 
regulation of proliferation, differentiation and apoptosis [3]. The mechanical properties 
of Mg alloys are similar to bone tissue, compared to available metallic alloys [4]. 
However, the main characteristic of Mg alloys is the fast degradation in physiological 
environment [5], which can be used as an advantage. As such, Mg alloys have been 
suggested for temporary bone implants, in the form of screw or bone plates. 
Nowadays, the main limitation of Mg-based metallic implants is controlling the 
degradation in physiological environment, insuring proper bone tissue regeneration 
before implant degradation. The fast degradation of Mg alloys can lead to excess of 
Mg2+ and increase risk of failure of the implant before the proper bone tissue 
regeneration. 
Many attempts have been proposed in literature to improve the lifetime of Mg 
implants, controlling its degradation rate to ensure durability and good bone adhesion. 
Firstly, alterations in the alloying composition of Mg alloys have been described useful 
in decreasing corrosion rate [5,6]. Anodisation is a method to increase corrosion 
resistance by creating a protection coating composed of Ca, P, F, O and H (β-TCP and 
CaHPO4.2H2O on the surface of the material [7]. Other methods describe the use of 
coatings based on calcium phosphate or hydroxyapatite (HA) [7,8,9] and polymeric 
coatings [10,11]. However, the barrier properties of these coatings are still poor and 
corrosion starts too soon, leading to reduction of the implant lifetime. 
Therefore, the improvement of the barrier properties and the accurate control of the 
corrosion rate of Mg alloys are the most important technical challenges to promote the 
use of innovative bioresorbable Mg implants, a new and growing market.  
Within this context, the project “A new generation of biodegradable implants 
obtained from magnesium alloys functionalized by means of advanced surface 
treatment” -  European Micro and Nano Technology Network, FP7 - 
ERAMNT/0002/2009, has been conducted by a consortium formed by Instituto 
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Superior Técnico da Universidade de Lisboa (IST, Coordinator), The Institute of 
Precision Mechanics (IPM) of the Faculty of Materials Science & Engineering, Warsaw 
University of Technology, the Materials Engineers Group sp. z o.o. (MEG), a spin-off 
company of the Faculty of Materials Science & Engineering, Warsaw University of 
Technology, and Faculdade de Medicina Dentária da Universidade do Porto (FMDUP). 
IST, IPM and MEG were responsible for the development and characterization of Mg-
based substrates, and FMDUP for the cytocompatibility and biocompatibility testing of 
the developed materials.  
The research work presented in this thesis has been performed at FMDUP, and 
includes the in vitro studies conducted during the several stages of the development of 
the Mg-based materials, providing information needed for the progressive optimization 
of the substrates with better biological response. 
Hence, the main objective of this work was to characterize the cytocompatibility of 
several Mg alloy surface treatments, including anodisation and polymeric-based 
coatings, in order to use these materials as biodegradable implants in orthopaedic 
applications. Firstly, the cytocompatibility of three Mg alloys - AZ31, AZ61 and RZ5 - 
was analysed in order to select the best ones. Subsequently, the porous layer created by 
plasma electrolytic oxidation (PEO) of the Mg alloy and composed of Ca, P, F, O and 
Mg, was also assessed for the cell response. At the final stage, two polymeric coatings, 
based on polyether imide (PEI) and polycaprolactone (PCL), used alone and with 
different concentrations of nanohydroxyapatite particles (HA), were tested. 
Cytocompatibility studies were performed using direct testing assays, i.e. the cells 
were seeded over the surface of the Mg-based substrates, and also indirect testing 
assays, in which the cell behaviour was assessed in the presence of extracts from the 
Mg-based materials. In the direct assays, MG-63 osteoblastic cells were used as the cell 
culture model. In the indirect assays, cell response was assessed for the behaviour of 
human mesenchymal stem cells, human osteoclastic cells and human endothelial cells. 
Cell response was analysed for cell viability/proliferation and specific phenotype 
parameters. 
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Following the motivation and the context for the development of this work, the 
thesis has the following structure: 
Chapter 2 contains a comprehensive state-of-the-art review on the most important 
topics discussed along the thesis. It contains information about bone physiology, 
magnesium biomaterials for bone regeneration, and in vitro and in vivo studies of 
magnesium alloys; 
Chapter 3 contains a detailed description of the materials and methods used in the 
experimental work. It describes the cell culture studies of the direct and indirect testing 
assays, detailing the methodology used in the characterization of the cellular behaviour; 
Chapter 4 includes the direct cytocompatibility studies, describing the osteoblastic 
cell behaviour over the Mg-based substrates, using MG-63 cells as the culture model; 
Chapter 5 describes the indirect cytocompatibility studies, namely the cell behaviour 
in the presence of the extracts from the Mg-based substrates and a set of Mg ion 
concentrations, using human mesenchymal stem cells, osteoclastic cells and endothelial 
cells as culture models; 
Chapter 6 contains the general discussion of this work; 
Chapter 7 enumerates the main conclusions of the conducted studies and future 
perspectives. 
 
The work developed in this thesis was partially published: 
Zomorodian A, GARCIA MP, Moura e Silva T, Fernandes JCS, Fernandes MH, 
Montemor, M.F. (2015) Biofunctional composite coating architectures based on 
polycaprolactone and nanohydroxyapatite for controlled corrosion activity and 
enhanced biocompatibility of magnesium AZ31 alloy. Materials Science and 
Engineering: C 48 (0): 434-443. DOI:10.1016/j.msec.2014.12.027 
Zomorodian, A., GARCIA, M.P., Moura e Silva, T., Fernandes, J.C.S., Fernandes, 
M.H., Montemor, M.F. (2013) Corrosion resistance of a composite polymeric coating 
applied on biodegradable AZ31 magnesium alloy. Acta Biomaterialia 9 (10): 8660-
8670. DOI: 10.1016/j.actbio.2013.02.036 
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Chapter 2 
General introduction 
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2.1 Bone Physiology 
 
Bone is a complex organ with an important role as structural support for the body 
and supporting movement and locomotion by providing levers for muscles, ligaments 
and tendons [12,13]. Bone tissue major functions also include protection and support of 
internal organs, mechanical support of the diaphragm, brain function, mineral ion 
homeostasis (calcium, phosphate), acid-base balance, reservoir of growth factors and 
cytokines, and provide the environment for haematopoiesis within the marrow spaces 
[12,13,14,15].  
Bone tissue is composed of mineralized osseous tissue, marrow, endosteum, nerves 
and blood vessels [14]. The cellular components of bone tissue are osteoblasts, 
osteocytes, bone-lining cells and osteoclasts. The extracellular matrix of the bone is 
composed of an organic matrix and a mineralized matrix. The organic matrix is mainly 
composed of type I collagen (90%), non-structural proteins (growth factors, osteocalcin, 
osteonectin, phosphoproteins), lipids and glycosaminoglycans (2%) [13,15,16]. 
The structure of the mineralized matrix can be discriminated into seven levels of 
hierarchy [17]. Firstly, the matrix is composed of nanoscopic plate-like crystals of 
carbonated hydroxyapatite (HA) (Ca10[ PO4 ]6[ OH ]2) that are oriented and aligned 
within self-assembled collagen fibrils; these fibrils are layered in parallel arrangement 
within lamellae. The lamellae are arranged concentrically around blood vessels to form 
osteons. The osteons are either packed densely into compact bone (or cortical bone) or 
comprise a trabecular network of microporous bone, referred to as spongy or cancellous 
bone [17,18]. In the cortical bone, the lamellae are regular and cylindrical in 
comparison to the irregular, sinuous convolutions of the structure in cancellous bone 
[12,14]. The adult human skeleton is composed of 80% cortical bone (or compact) and 
20% cancellous bone (trabecular or spongy) overall [12]. The microstructure of the 
bone comprises the harversian system, osteon and single trabeculae [14]. 
Cortical osteons are called Harversian systems, which are cylindrical in shape, 
approximately 400 mm long and 200 mm wide at their base, and form a branching 
network within the cortical bone (Figure 1) [12]. The walls of Harversian systems are 
formed of concentric lamellae [12]. Cortical bone has an outer periosteal surface and an 
inner endosteal surface [12]. Trabecular osteons are called packets, which are composed 
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of plates and rods averaging 50 to 400 mm in thickness [12]. Trabecular osteons are 
semilunar in shape, normally approximately 35 mm thick, and composed of concentric 
lamellae [12]. 
 
 
Figure 1. Schematic representation of bone structure [19]. 
 
The cellular components of the bone include osteocytes, osteoblasts, osteoclast, 
bone-lining cells and mesenchymal stem cells (MSC). Mesenchymal stem cells have the 
potential to differentiate into fibroblasts, osteoblasts, osteocytes, adipocytes and 
chondrocytes [20]. The process of differentiation is controlled by the expression of 
lineage-specific transcription factors, growth factors and cytokines.  
Osteoblasts are elongated cells derived from MSC and responsible for the 
production of the organic matrix of the bone [16]. The differentiation of MSC into 
osteoblasts and the bone calcification is controlled by transcription factors Runt-related 
transcription factor 2 (Runx2) and Osterix [16,20]. Osteoblasts are responsible for the 
expression of genes necessary for calcification and induction or downregulation of 
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osteoclasts [15,21]. Osteoblasts might be encased in the extracellular matrix as 
osteocytes, or remain on the bone surface as bone-lining cells [16]. 
Osteoclasts are large multinucleated cells derived from bone marrow hematopoietic 
stem cells (HSC) with an important role on bone reabsorption [15,16]. 
Osteoclastogenesis is regulated by transcription factors PU.1, AP-1, Nuclear factor 
kappa-light-chain-enhancer of activated B cells (NF-kB) and nuclear factor of Activated 
T-Cells (NFATc) [20]. Some of the growth factors/cytokines controlling 
osteoclastogenesis are Macrophage colony-stimulating factor (M-CSF) and Receptor 
activator of nuclear factor kappa-B ligand (RANKL) which are synthetized by 
osteoblasts. Both have a positive role in the expansion of the precursors and osteoclast 
differentiation. Osteoprotegerin (OPG), also synthetized by osteoblasts, has a negative 
role in osteoclastogenesis [20]. 
Bone formation, growth and remodelling are regulated by hormones, growth factors 
and cytokines (such as IGF-I, BMPs, FGFs, Wnt, Notch, PTH) and also by nutrition, 
mechanical loading and aging [20]. These factors will activate different pathways that 
are important in the remodelling of the bone tissue. Bone remodelling is a process in 
which osteoclasts perform bone resorption and later osteoblasts form new bone. This 
process involves three sequential steps: resorption, reversal and formation of bone [13]. 
Bone lining cells express RANKL which will bind to a surface receptor on the 
membrane of pre-osteoclasts (RANK, Receptor activator of nuclear factor kappa-B). 
The binding of RANKL will activate a signalling cascade for osteoclast activation and 
commitment (Figure 2) [13]. Osteocytes might have an essential part in this process, 
since it has been proposed that they sense microcracks and microfractures triggering 
osteoclast differentiation and bone resorption [13]. It has been proposed that osteocytes 
can regulate the expression of RANKL in osteoblasts, which in turn will influence 
osteoclastogenesis. Osteocytes are connected by cytoplasmic processes to each other 
and other types of cells, such as osteoblasts [13]. 
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Figure 2. Schematic representation of osteoclastogenesis regulation by 
osteoblasts/stromal cells. The presence of M-CSF will induce the differentiation and 
proliferation of osteoclasts [22]. 
 
In the resorption phase, the osteoclast progenitors will differentiate into active 
osteoclasts that can dig trenches with a depth of 40 – 60 μm in the bone [13]. This phase 
is followed by the reversal phase in which osteoblast precursors differentiate to 
osteoblasts and osteoclasts undergo apoptosis, discontinuing bone resorption [13]. At 
this phase, osteoblasts lay down new bone material (mainly collagen type I, but also 
osteocalcin, osteopontin, along with a large variety of other bioactive molecules) until 
the reabsorbed bone is replaced by a new one [13]. The osteoblasts that stay encased in 
the new bone matrix during bone formation are transformed to osteocytes [13]. The 
osteoblasts become quiescent at the end of bone remodelling forming flattened lining 
cells on the bone surface [13]. 
The various components of the bone are organized in a way that bone is able to 
perform diverse mechanical, biological and chemical functions [14]. The major factor to 
determine the mechanical properties of bone is based in the hierarchical structure of this 
tissue. The combination of bone components gives the tissue mechanical properties that 
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have been difficult to reproduce by biomaterials science. Bone tissue presents a low 
density, from 0.2 g/cm3 in cancellous structure to 1.80 g/cm3 in cortical bone. In cortical 
bone, tensile strength can vary from 35 to 283 MPa, compression strength from 164 to 
240 MPa and elastic modulus between 5 and 23 GPa [4,23]. 
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2.2 Magnesium Biomaterials for Bone Regeneration 
 
In the last decades an increasing interest in magnesium alloys for bone tissue 
applications was evident. However, the interest in magnesium for medical applications 
started 200 years ago, shortly after the discovery of elemental magnesium [24]. Reports 
of the use of magnesium as a biomaterial go as far as 1878 where magnesium wire was 
used to stop bleeding vessels of three patients [24]. 
Various applications have been purposed for magnesium biomaterials, such as 
screws, bone plates and stents. In case of a complex fracture, due to accident or disease, 
the bone may require to be fixed with an internal implant (screws or plates), with the 
need of a surgical intervention. Current commercial options for this application can be 
made of titanium, stainless steel or cobalt-chromium alloys, and are permanent implants 
[25]. One of the disadvantages of commercial options is that, after 1 or 2 years, the 
implants need to be removed; therefore a second surgery is required. Biodegradable 
implants can reduce the life-long problems caused by permanent implants which include 
long-term endothelial dysfunction, permanent physical irritation and chronic 
inflammatory local reactions [26]. 
Also, for orthopaedic applications the mechanical properties of the implanted 
biomaterial should be similar to the tissue being regenerated. This ensures proper 
support in the early healing stages and graded load transfer later during the formation of 
replacement tissue [27,28]. The mechanical properties to be considered for these 
applications include compression, tension and torsion. Compressive properties should 
be an important concern when the material is applied to cancellous bone, while tensile 
properties should be taken in to consideration in the cortical bone [28]. The titanium and 
stainless steel implants currently available have mechanical properties different from 
bone such as a higher Young modulus (Table 1) [29]. As a result these implants are too 
stiff compared to the adjacent cancellous bones creating stress shielding. Mechanical 
stress such as internal loads, which are usually carried by the bone, will be mainly 
supported by the implants creating this effect called stress shielding [25]. There are 
several clinical complications associated with this problem, such as early implant 
loosening, damage to healing process and adjacent anatomical structures, skeleton 
thickening and chronic inflammation [25]. The stress-shielding phenomena caused by 
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metallic implants (stainless steel or titanium alloy) could be minimized by the use of 
magnesium alloy [30]. Magnesium alloys present mechanical properties closer to the 
values observed in natural bone [4]. These characteristics include density, elastic 
modulus and compressive yield strength. Elastic modulus of magnesium alloys (40 – 45 
GPa) is similar to bone (3 – 20 GPa) (Table 1) [29]. Also, when compared to 
hydroxyapatite and other ceramic biomaterials, the elastic modulus and fracture 
toughness of magnesium alloys is higher [29]. 
Other biodegradable implants have been developed, such as resorbable polymer 
fixation plates and screws but they have demonstrated to be relatively weak and less 
rigid compared to metals [31,32]. 
 
Table 1. Physical and mechanical properties of biomaterials used for bone tissue 
applications [29]. 
Properties 
Natural 
bone 
Magnesium Ti alloy 
Co-Cr 
alloy 
Stainless 
steel 
Synthetic 
hydroxyapatite 
Density (g/cm3) 1.8 – 2.1 1.74 – 2.0 4.4 – 4.5 8.3 – 9.2 7.9 – 8.1 3.1 
Elastic modulus (GPa) 3 - 20 41 – 45 110 - 117 230 189 – 205 73 - 117 
Compressive yield strength 
(MPa) 
130 - 180 65 – 100 
758 - 
1117 
450 - 
1000 
170 – 310 600 
Fracture toughness 3 - 6 15 – 40 55 - 115  50 – 200 0.7 
 
 
The interest of magnesium alloys for bone regeneration relies on the similarity of 
mechanical properties compared to bone, however between magnesium alloys the 
mechanical properties are also different. Magnesium mechanical properties show a 
discrepancy depending on composition, cast method and trace elements present [5,33]. 
Pure magnesium, with 99% of magnesium and a small percentage of other elements has 
a density of 1.74 to 2.0 g/cm3. The elastic modulus varies from 41 to 45 GPa, 
compressive yield strength from 65 to 100 MPa and fracture toughness from 15 to 40 
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MPam½ [29] (Table 2). Gu and coworkers (2009) reported that magnesium with 
alloying elements such as Al, Ag, In, Si or Zn would have an improvement in yield 
strength and tensile strength compared to pure magnesium (Table 2) [5]. 
 
Table 2. Mechanical properties of different magnesium alloys used in bone tissue 
applications [4,34]. 
 
Cortical 
bone 
Mg-cast 
AZ91E-
F sand 
cast 
AZ31 
extruded 
AZ31 sheet LAE442 
Mg-1Ca-
extruded 
Mg-Zn-
Mn-
extruded 
Compression 
strength (MPa) 
164 – 240  97 83 – 97 110 – 180    
Tensile strength 
(MPa) 
35 – 283 86.8 ± 2.5 165 241 – 260 255 – 290 247 
239.6 ± 
7.2 
280.3 ± 
0.9 
E-mod. Tensile 
(GPa) 
5 – 23 41 45      
Density (g/cm3) 1.8 – 2.0 1.74 1.81  1.78    
Yield strength (MPa)  20.9 ± 2.3 97 165 – 200 150 - 220 148 
135.6 ± 
5.4 
246.5 ± 
4.5 
 
 
Magnesium is one of the most important cations in the human body, mainly present 
in the bone (60 to 70% of the total amount) [1,2]. Magnesium is also present in the soft 
tissue and extracellular compartments [1]. The homeostasis of magnesium is performed 
by three major organs, small bowel (absorption), kidneys (excretion and reabsorption) 
and bone [35]. The bone assists as a reservoir for magnesium since up to one third of 
this magnesium is exchangeable. In case of deprivation, magnesium present in the bone 
can be used to supplement the serum levels of magnesium [36]. In the cells, magnesium 
has an important role in the maintenance of membrane integrity, increasing the 
resistance towards oxidative stress and regulation of cell proliferation, differentiation 
and apoptosis [3]. The Mg present in the muscle, soft tissues and erythrocytes is 
considered intracellular Mg [35]. This Mg is preferentially bound to chelators such as 
negatively charged molecules, membranes and ATP [1]. It is, also, a regulator of more 
than 350 proteins, stabilizer of DNA and RNA and co-regulator and activator of 
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integrins (cell migration) [4]. Part of the intracellular Mg, 5 to 10%, is in the ionized 
form and have an important role in regulating intracellular homeostasis [35]. 
Extracellular Mg, present in the serum, is mainly in the ionized form (67%), protein 
bound (19%) and complexed (14%) [35]. Both, protein bound and complexed Mg are 
unavailable for most biochemical processes. Mg can act as a calcium blocker and 
control intracellular calcium, i.e. an increase in extracellular Mg decreases the 
intracellular calcium [37,38]. In normal cells, the regulatory effect of Ca2+ is mediated 
through Mg2+-dependent processes. Hypomagnesemia is also associated with an 
imbalance of electrolytes such as Na+, K+ and Ca2+ [35,39]. 
 
One of the most important features of magnesium alloys is their ability to corrode in 
aqueous systems. This is a determinant factor for magnesium alloys to be used for bone 
tissue regeneration as temporary implants. Therefore, the control of corrosion rate is one 
of the most important features to take into account when designing a magnesium 
biomaterial. 
In aqueous solutions, magnesium alloys react producing hydrogen and a magnesium 
hydroxide layer:  
(1)    Mg + 2H2O ⇒ Mg(OH)2 + H2. 
In the presence of chloride ions, in environments such as cell culture medium or 
body fluids, the magnesium hydroxide dissolves into MgCl2 salt:  
(2)    Mg(OH)2 + 2Cl- ⇔ MgCl2 + 2OH [40]. 
Interaction with artificial body fluids (Hank’s solution or simulated body fluid) can 
result in the formation of magnesium hydroxide, magnesium oxide, magnesium 
chloride, as well as calcium and magnesium apatites [41]. The formation of magnesium 
hydroxide can lead to the elevation of pH in the surrounding environment. Although 
magnesium hydroxide can act as a corrosion protective layer in water, in high 
concentration of chloride it is converted to a highly soluble magnesium chloride [4,26]. 
The presence of biomolecules, such as bovine serum albumin, can also increase the 
dissolution rate of magnesium hydroxide and inhibit the deposition of calcium 
phosphate on Mg substrates [42]. Hydrogen gas is an important effect of corrosion and a 
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major concern for using Mg-based alloys in orthopaedic applications because bone 
poorly vascularizes and transports the excessive gas, potentially resulting in the 
formation of harmful gas pockets [26,43]. Although, the hydrogen gas can be 
exchanged through the skin or accumulate in fatty tissue, therefore decreasing its effects 
[26]. 
The corrosion of magnesium alloys is dependent of the following parameters: 
composition of Mg alloy, metallurgical treatments, surface treatment, composition of 
the contacting electrolyte, pH and buffer capacity of the electrolyte, mechanical inputs 
such as compression or bending forces, biological environment, presence of biological 
molecules and transport phenomena associated with the reactants and products of the 
corrosion reaction [40].  
In physiological environment, Mg alloys can be affected by two types of corrosion, 
pitting corrosion and galvanic corrosion. Corrosion is typically localized in single-phase 
materials, resulting in the formation of pits on the surface of the material [44,45]. The 
presence of a secondary phase due to impurities or alloying components results in 
galvanic corrosion. In this type of corrosion, the secondary phase acts as a local cathode 
resulting in localized corrosion [45]. 
In the human body, magnesium implant will be exposed to various constituents of 
the body fluids, such as proteins, anions (chloride, phosphate, bicarbonate), cations 
(Na+, K+, Ca2+, Mg2+ etc.), organic substances of low molecular-weight species, 
relatively high molecular-weight polymeric components, as well as dissolved oxygen 
[46,47,48]. This physiological environment makes an extremely complex corrosive 
medium. In case of high concentration of chloride, i.e. human body, magnesium 
hydroxide will be converted to magnesium chloride inducing pitting corrosion [40,49]. 
Other ions also influence corrosion of magnesium alloys in physiological environment. 
It was  reported that hydrogen carbonate ions would stimulate the overall corrosion of 
magnesium alloys [50]. The same authors reported an increase in corrosion resistance 
with increasing of HPO42- concentration due to the formation of a stable passivation 
layer. The presence of HCO3-, Ca2+ and HPO42- together decreases the corrosion rate of 
Mg alloys surface due to the formation of insoluble HA [50]. 
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The development of magnesium alloys suitable for biodegradable implants is 
dependent on the control of corrosion rate and mechanical integrity of the implant in 
physiological environment. Several techniques have been used to improve corrosion 
resistance and the mechanical properties of Mg alloys, such as alloying Mg, surface 
modification of the substrate and various coatings techniques [44]. A set of approaches 
for surface modifications are based in the formation of a biomimetic layer (composed of 
Ca, P and C) [7,51,52]; moreover other coatings have been used such as hydroxyapatite 
[8] or polymers (such as polycaprolactone (PCL), polyether imide (PEI), poly-(L-lactic) 
acid (PLLA), poly(lactic-co-glycolic acid) (PLLC)) [10,11,53,54,55,56]. 
These treatments are interesting for degradable implants because the corrosion rate 
is intended to be low in the initial phase due to the modified surface layer and then 
returns to the normal value when the layer corrodes away [57]. Such degradation pattern 
is desirable since the loss of strength of the implant would mirror the increase in 
strength of the healing bone, providing sufficient support in the initial phase [57]. 
One of the methods used to modify Mg alloys is through alloying, i.e. selecting the 
composition of the alloys. The composition of the alloys can affect their strength, 
ductility and corrosion properties [44,58]. 
Mg alloys have been developed for industry and consequently the same alloys were 
used in biomaterials research. These alloys usually contain aluminium and rare earth 
elements. Aluminium is one of the most common alloying elements used in metal 
biomaterials, such as titanium implants [4]. Although its use is approved in such 
biomaterials, several reports concerning its toxicity for the human body have been 
published. Aluminium has been described as risk factor for Alzheimer and Parkinson 
disease [59]. Rare earth elements (yttrium (Y), cerium (Ce), lanthanum (La)) are known 
to have anticarcinogenic properties but the effects in humans are still unclear [4,60]. Mg 
alloys such as AZ91, AZ31, AE21 and LAE442, with aluminium in their composition, 
have been tested for biomedical applications. Magnesium alloys with rare earth 
elements studied for biomedical applications include WE43 and LAE442 [58]. 
Other Mg alloys have been studied for these applications using non-toxic elements 
such as calcium (Ca), manganese (Mn), zinc (Zn) and zirconium (Zr) [44]. Zinc is an 
important trace element found in several human tissues, such as skin, bone, liver, 
muscles and brain [61]. In the bone, zinc has an important role in the growth, 
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development and maintenance, and deficiency can lead to bone growth retardation [62]. 
It is also required in a variety of cellular processes, including DNA and protein 
synthesis, enzyme activity and intracellular activity [63]. Other alloying elements (Ca, 
Cr, Mn, Sn, Si) are also nutrients present in human body. Calcium is an important 
macronutrient, mainly presented in the bone (99%) in the form of hydroxyapatite [64]. 
Other alloying components also investigated include lithium, cadmium, strontium and 
silicon [44]. Also, most alloys have impurities such as iron, copper, nickel and 
beryllium [33]. For biomedical applications, the amount of impurities should be kept 
minimal, especially those known to create deleterious effects in the human body 
[33,43]. Impurities could also have an important effect in the characteristics of the alloy, 
most important in the corrosion resistance of the alloy [43]. 
The addition of Al in Mg alloys can improve strength, corrosion resistance and 
increase oxidation rate [44,65]. Although Al can increase at corrosion resistance up to a 
certain level, at higher concentrations the opposite effect is observed due to increased 
presence of Mg17Al12 phase that promotes galvanic corrosion [66,67]. Rare earth 
elements are also used to increase strength, ductility, corrosion resistance and creep 
resistance of the material [4,33,44,68]. They can improve corrosion resistance in high 
chloride environments due to the formation of an oxide passivation layer [69,70]. Other 
components such as In, Mn, Zn or Zr can also reduce the corrosion rate [5]. The 
opposite behaviour was observed in alloying elements such as Si and Y. Zinc is also 
known to increase the oxidation rate, whereas rare earth elements decrease the oxidation 
rate of magnesium alloys [65]. In a study performed by Kirkland and co-workers (2010) 
increasing concentrations of Ca were used to enhance the corrosion rate [6]. Also, the 
corrosion rate of MgCa alloys was significantly reduced when the corrosion fluid used 
had higher concentration of proteins [6,71]. 
Surface roughness can influence the corrosion rate of magnesium alloys. Nguyen et 
al. (2012) observed an acceleration of corrosion with the increase of roughness, in pure 
magnesium [72].To increase the degradation resistance, Kannan et al. (2011) performed 
mechanical alterations in the surface of the magnesium alloy, using friction stir 
processing [73]. AZ31 alloy treated by friction stir presented a higher degradation 
resistance compared to non-treated AZ31 alloy, when incubated with SBF. Corrosion 
rate is also affected by casting process has observed by Zhang et al. (2012) [74].  
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An option to adjust the corrosion rate is the formation of a protective layer. In vitro 
tests have shown that incubation of pure Magnesium with cell culture medium, up to 24 
hours, increase corrosion protection [51]. A biomimetic layer composed of Ca, P and C 
is rapidly formed, decreasing the amount of H2 liberation and corrosion rate of 
magnesium materials [51].  
A method used to produce a biomimetic layer is anodisation, which can create a 
precipitate composed of Ca, P and F (β-TCP and CaPO3(OH)) on the surface of the 
material [7]. The anodisation of magnesium is an electro-chemical process that changes 
the surface chemistry of the metal, via oxidation, to produce a stable anodic oxide layer. 
The structure of this layer is characterized by a thin barrier layer at the metal-oxide 
interface, followed by a less dense porous oxide layer. The porous layer can display a 
variety of different structures and properties which are dependent on the composition, 
substrate micro-structure and processing parameters [75,76,77]. The processing 
parameters that influence oxide layer formation include: 1) the type, temperature and 
concentration of electrolyte; 2) current density; and 3) the applied anodisation voltage. 
These parameters can also significantly influence the resulting corrosion behaviour of 
the substrate [76]. The coating formed in magnesium has been shown to decrease 
corrosion rate in in vitro testing simulating physiological environment in previous 
reports [7,78,79,80]. Anodised AZ31 presented a higher corrosion resistance in the 
initial stages of corrosion and retardation of the uniform corrosion and localized 
corrosion mechanisms during immersion in physiological environment [9,81]. The 
ceramic coating formed has shown to be maintained up to 28 days with no significant 
degradation (incubated in physiological environment), and degradation is observed only 
after 60 days; AZ31D alloy showed evidence of degradation after 4 days [81]. Tan and 
co-workers (2010) reported a reduction in corrosion rate of AZ31 alloys after being 
submitted to the process of anodisation [7]. Moreover, the corrosion of this layer is 
determined by the corrosion resistance of the base material [82]. The implication of this 
observation is that the same coating on different magnesium alloys will result in 
different corrosion rates. 
Polymer coating have been used for numerous biomedical applications, such has 
bone plates and screws, bone cement, catheters, vascular grafts and surface coatings 
[83]. Polymeric coatings have been applied to enhance corrosion resistance, abrasion 
and wear properties of magnesium alloys for biomedical applications [75]. Various 
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polymers have been used for this application such as PCL, PEI, PLLA and PLLC, 
polyvinyl acetate (PVAc) [10,11,53,54,55,56,84,85,86,87]. The coatings showed a 
better performance compared to uncoated samples when incubated in physiological 
environment, with a delayed start of degradation [10,11]. Furthermore, these coatings 
have shown to increase biocompatibility of coated magnesium alloys in vitro [86,88]. In 
vivo tests have shown a delayed degradation and a higher formation of bone on coated 
alloys after implantation in a rabbit model [88]. 
PEI is an amorphous polymer that has been studied for magnesium coating showing 
promising results as a corrosion treatment [53,84,85,87,89]. PCL has also been used as 
coating for magnesium alloys presenting promising results, decreasing corrosion rate 
and augmenting biocompatibility of the alloys [10]. Compared to PLLA, the authors 
found a lower adhesion of the coating to the magnesium alloy, which could be attributed 
to the molecular structure of the both polymers [10]. 
Wong and co-workers (2010) tested a polymeric coating composed of 
polycaprolactone and dichloromethane. The report showed not only a reduced corrosion 
rate of the coated magnesium alloys but also that the coating aided in retaining the 
mechanical strength of the implant. Other study compared the efficiency of a PCL and a 
PLLA coating in corrosion protection [10]. In this work, both coatings exhibited better 
corrosion protection compared to the uncoated sample. Further, PLLA showed better 
overall performance. PEI has shown promising results to control corrosion of AZ31 
[53]. The authors also reported a better performance of the coating when it exhibited 
microporous. In the case of non-porous polymers, the integrity of the layer could not be 
guaranteed due to hydrogen gas production, eventually resulting in the corrosion of the 
metal surface [53]. 
Rosemann and co-workers (2012) used a combination of anodic oxidation and a 
PLLC coating to enhance protection against corrosion [11]. Anodic oxidation led to the 
reduction of hydrogen evolution, however it could not delay the beginning of 
degradation. Moreover, the combination of both approaches was found to delay 
degradation in biological fluid [11].  
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2.3 In vivo and in vitro studies of magnesium alloys 
 
Literature regarding the use of magnesium alloys as implants has shown a good 
compatibility and minor adverse effects, especially in in vivo tests [7,33,52,90,91,92].  
Magnesium alloys were found to have osteoconductive and osteoinductive 
properties, contributing to a less invasive repair and a temporary support during tissue 
recovery [93]. Also, the fact that the alloys can be dissolved or absorbed by the body is 
an advantage compared to permanent implants, since the later can cause mismatches in 
the behaviour between the implant and the body, inducing physical irritation and 
chronic inflammatory reactions [30]. Biodegradable Mg alloys have been reported to 
have higher bone-implant interface strength than titanium, a well-stablished material for 
bone tissue applications. A Mg alloy (Mg–Y–Nd–HRE, based on WE43) showed a 
higher stability and osteointegration after transcortical implantation in rats, when 
compared to titanium implants [94]. A MgCa0.8 screw implant also showed good 
biocompatibility and biomechanical properties, comparable to stainless steel [95]. In a 
study using two different Mg-based implants, ZX50 and WZ21, reported a similar result 
[96]. These implants, when implanted in Sprague–Dawley rats, presented a good 
biocompatibility. Normal bone growth after degradation of the Mg implants was 
observed, even in ZX50 which has a higher degradation rate and massive gas formation 
is observed [96]. 
In a study using guinea pigs as animal model, the implantation of magnesium alloys 
(AZ31, AZ91, WE41 and LAE442) showed a better performance compared to a 
degradable polymer [33]. A higher bone mass and mineral apposition rate was observed 
close to magnesium implants. The same authors described a better implant performance 
in magnesium alloys with rare earth materials in their composition [33]. In implants 
prepared from LAE442, it has been report a decrease in osteopontin and osteocalcin 
expression throughout the implantation time, which is an indicator appropriate 
biocompatibility [97]. Also, it has been found a decrease in the corrosion rate up to 4 
orders in in vivo results, compared to in vitro [8]. Henderson et al. (2014) described a 
good performance of Mg alloys for degradable craniofacial bone screws [98]. Pure Mg 
and AZ31 alloy implanted in a rabbit mandible presented a good biocompatibility, with 
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no evident signs of inflammatory response. Mg-Zr alloys have also been reported to 
induce mineralization when implanted in New Zealand white rabbits [99].  
To control corrosion rate, a plasma anodisation film was created in the surface of 
Mg-Zn-Ca alloy and a better biocompatibility response was reported for anodised 
material compared to base alloy [100]. A MgZnCa glass has been studied to control 
corrosion rate and decreasing hydrogen evolution, [101]. Reports showed a decrease in 
hydrogen evolution in vitro and in vivo and similar tissue biocompatibility compared to 
crystalline Mg implants.  
AX30 Mg alloy coated with MgF2 or CaP/ MgF2 showed a good biocompatibility 
when implanted in rabbit femurs[102]. When comparing both coatings, it was observed 
a better osseointegration by osteoid and mineralized bone formation in MgF2. The 
results were related to a decrease in degradation observed in Mg alloys with MgF2 
coating. In another study, AZ31 coated with Ca-P was reported to increase 
biocompatibility and bone regeneration when implanted in rabbits [103]. The 
implantation of AZ91 and a merwinite/PEO coated AZ91 in rabbits showed an 
improvement in the biodegradability and biocompatibility, including an increase in the 
bone formation, in coated samples [104]. 
In vitro cytocompatibility testing can involve an indirect assay (ISO 10993-5 [105]), 
in which the cultured cells are exposed to an extract of the material to be tested; or a 
direct test (ISO 10993-12 [106]), in which the cells are seeded on the surface of the 
biomaterial. In indirect assays, the extracts are prepared by immersion of the material in 
culture media for 24 to 72h. In this assay, the cytotoxic or proliferative effects of the 
materials are then measured in the cells exposed to the extracts [44]. The results 
obtained in both assays can show great discrepancies. Jung et al. (2015) analysed the 
biocompatibility of a series of Mg-based alloys in both direct and indirect assays [107]. 
Although in direct tests pure Mg showed a poor cytocompatibility while WE43 had a 
better result, in indirect tests both materials presented a poor cytocompatibility [107]. 
Pure Mg was found to support the adhesion, differentiation and growth of stromal 
cells (obtained from Wistar rats) towards an osteoblast-like phenotype with the 
subsequent production of a bone like matrix after 17 days of culture [91]. The same 
authors found no significant difference between pure Mg, AZ21 alloy or a 0.5 wt% Ca 
alloy. The worst result was found in a 0.8 wt% Ca alloy, presenting a total 
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disintegration of the material, which showed minimal cell growth [91]. Zhang et al. 
(2012) performed an indirect test to evaluate the cytotoxicity of various Mg-Nd-Zn-Zr 
alloys, with different casting methods [74]. The incubation of L929 cells with 
magnesium extraction medium showed a small decrease in viability, still in the range 
requirements of cell toxicity for biomaterials. Hänzi et al. (2010) also obtained a good 
cytocompatibility of two Mg–Y–Zn alloys (ZW21 and WZ21) when performing 
indirect cell testing using HUVEC’s [90]. In another study, MG63 cells cultured on the 
surface of AZ31 alloy presented decreased in viability after 48 hours in culture [7]. In 
other work, hMSC did not proliferate in direct contact with a Mg-Ca alloy [108]. Pure 
Mg and bulk metallic glass, Mg65Zn30Ca5, were capable of supporting adhesion and 
viability of L929 cells cultured in the surface of the material [109]. In an indirect test, 
hMSC have shown to be highly affect by Mg-based extracts [110]. In this study, Mg-
based extracts showed a cytotoxic effect on hMSC, when added at high concentration. 
At lower concentrations, the extracts were able to increase proliferation and 
differentiation of hMSC. Mg-based extracts have also been described to induce the up-
regulation of osteogenic markers, such has ALP and osteocalcin, in MG-63 [111]. 
U2OS osteoblastic cells seeded in the presence of Mg alloys showed an expression and 
enzymatic activity of ALP and mineralization similar to control cultures [112]. Extracts 
from Mg-REE (rare earth elements) are reported to be toxic to MC3T3 cells, at high 
concentrations [113]. 
The rate of corrosion has a direct effect in both direct and indirect biocompatibility 
outcomes. It has been reported that Mg alloy with higher corrosion rates will show less 
cell growth in the surface of materials as well as a higher toxicity rate in indirect assay 
[114]. 
Zhao et al. (2014) compared the results of both types of cytocompatibility studies, 
using endothelial cells, of pure magnesium and magnesium-rare earth alloys [115]. The 
indirect study revealed no significant differences between pure magnesium and 
magnesium-rare earth alloys. The opposite was observed in the direct test, with a better 
attachment and spreading of endothelial cells in the magnesium-rare earth alloys [115]. 
As referred above, in the direct assay, magnesium alloys show a poorer performance 
compared to that observed in the indirect assays, which is related with the high 
corrosion rate of these materials. However, the concentration of magnesium ions alone 
may not be responsible for the decrease in cell density, spreading and alterations in 
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morphology, as observed by Keim et al. [51]. Even in the presence of high magnesium 
concentrations in the medium, such as 750 mg/L, HeLa cells were able to attach and 
grow. Magnesium ions are also known to stimulate adhesion of osteoblastic cells when 
added to alumina (Al2O3) biomaterials, commonly used in orthopaedic implants [116]. 
A major factor in the cell adhesion behaviour is the corrosion rate upon exposure of 
cells to Mg surface [51]. The discrepancy between the various studies, especially the 
ones using the same alloys, is possibly due to the surface alterations occurring with the 
corrosion and not from direct cytotoxicity of Mg materials. Cells are exposed to H2 
bubbling and pH increase in the medium when in contact with Mg surface, decreasing 
their ability to adhere and proliferate. In surfaces previously exposed to culture medium, 
presenting a biomimetic layer (Ca, P and C), the cell adhesion and spreading will be 
enhanced compared to pure Mg polished surfaces [51]. 
AZ31 alloys have been described to have a good performance in vivo (implanted in 
rabbits), with no chronic inflammation being observed [52]. After 8 weeks, the 
formation of new bone could be seen close to the implant. In the same period, AZ31 
alloy coated with Ca-P presented a reduction in the biodegradation compared with 
naked AZ31. Also, more osteoid formation was found in Ca-P coated samples [52]. In 
another study, surface treatment with microarc oxidation coating performed in a Mg-Ca 
alloy resulted in a better corrosion resistance compared to the naked sample [117]. The 
coated samples revealed to be more efficient in promoting cell adhesion and spreading 
compared to Mg-Ca naked sample, and presented a better biocompatibility [117]. AZ31 
scaffolds coated with Ca-P showed enhanced biocompatibility in MSC cultures 
compared to base sample, in an indirect assay [103]. MSC cultured in the surface of 
base and coated samples showed a reduced viability, although the results were in 
accordance to that observed in the indirect assay, i.e. better performance of the coated 
samples.  
The surface passivation of pure Mg alloy, which creates a Ca/Mg-phosphate layer, 
has been described to enable HeLa cells adhesion to the surface of the alloys and 
enhance its biocompatibility [118]. 
A surface treatment by anodisation as reported to increase the corrosion resistance of 
three Mg alloys, AZ31B, AZ91E and ZK60A [119]. MC3T3 cells cultured in the 
presence of extracts from ZK60A and anodised sample showed a decreased viability. 
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Both, AZ31 and AZ91 showed an increase in viability of MC3T3 cells, especially the 
anodised samples [119]. 
A strategy to improve corrosion properties and biocompatibility is the formation of a 
metal matrix composite, using HA particles. Witte et al. (2007) used an AZ91D alloy in 
combination with HA particles, improving corrosion properties and lowering the pH 
compared to the base material [8]. Human bone derived cells, MG-63 and RAW 264.7 
cells cultured in the surface of these materials were able to adhere and proliferate in 
both corroding surface, although an increased in cell viability and proliferation was 
observed in the composite alloy [8]. Another study using a HA coating or a HA/TiO2 
showed similar results. MG-63 cells seeded in the surface of these coatings showed an 
increase in viability/proliferation compared to base Mg (2.83% Al, 0.8% Zn, 0.37% Mn, 
0.002% Cu and balance Mg) [120]. Iskandar et al. (2013) reported an increase in 
adhesion and cytocompatilibity of bone stromal cells cultured in the surface of 
nanostructured HA-coated Mg alloys compared to the base materials [121]. Also, an 
improvement in biodegradation of the coated samples was observed. 
Polymeric coatings have also been applied to control corrosion rate of Mg alloys. 
PLGA polymer applied in surface of AZ31 and Mg4Y improved the biocompatibility of 
mouse osteoblasts cultured in the surface of Mg alloy and provided corrosion protection 
[122]. In another study, PCL, PEI and PLGA where used to provide a protection layer 
in AZ31 alloy. MC3T3 cells cultured in the surface of these coated materials showed a 
increase in viability and proliferation compared to uncoated samples [89]. Xu and 
Yamamoto (2012) performed a study using polymer films (PLLA and PLC) to enhance 
the resistance to corrosion of pure magnesium [10]. The pH measurement and Mg2+ 
release were significantly decreased in coated samples. These polymer films provided a 
significantly better cytocompatibility than uncoated magnesium materials, when SaOS-
2 cells were cultured on their surface [10]. 
PVAc has also been used to control corrosion rate when applied to the surface of Mg 
alloys. Osteoblast cells MC3T3 seeded in the surface of polymeric coated samples 
showed a high adherence, proliferation and survival compared to the results observed in 
uncoated sample (AM50) [86]. PLA polymer with incorporated HA particles has been 
observed to control corrosion rate and increase biocompatibility. Both, PLA coated 
samples and HA-doped PLA samples, showed an increase in corrosion resistance 
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accompanied by an increase of cell growth, when MC3T3 cells were cultured in the 
presence of extracts of the materials [123]. 
Wong and co-workers (2010) have used a polycaprolactone and dichloromethane 
coating to enhance the biocompatibility of AZ91 alloy [88]. In vitro tests, using eGFP 
and SaOS-2 osteoblasts, indicated a better performance of the coated samples when 
compared to bare AZ91. Moreover, rabbits that have been implanted with both 
materials showed bone formation, without evidence of inflammation, necrosis or 
hydrogen gas accumulation. The major differences between implants were the earlier 
degradation of uncoated samples and the lower volume of new bone in these samples 
[88]. 
Zhao and co-workers (2014) showed that endothelial cells (HCAECs) had better 
attachment, spreading, growth and proliferation on magnesium materials coated with 
fluoride when compared to collagen coating or uncoated samples [54]. 
Magnesium alloys present an interesting set of characteristics that make then 
suitable for bone tissue regeneration, especially their mechanical characteristics. The 
major difficulty in their use is the fast corrosion rate in physiological conditions. 
However, a variety of surface treatments are being developed to control the corrosion 
rate of magnesium alloys, improving significantly the in vivo and in vitro performance 
of these materials. 
 
  
 
 
 
 
 
Chapter 3 
Materials and Methods 
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The cytocompatibility of Mg alloys and further surface treatments was analysed in 
direct assays, i.e. cells were cultured on the surface of the materials, and also using 
indirect assays, i.e. cells were cultured in the presence of extracts from the Mg-based 
substrates. 
 
3.1 Direct cytocompatibility assays  
The following surfaces were analysed: (i) naked AZ31, AZ61 and RZ5 alloys, (ii) 
anodised AZ31 and RZ5 alloys, (iii) several compositions of PEI/HA coated AZ31 alloy 
(Table 3) and (iv) several compositions of PCL/HA coated AZ31 alloy (Table 4). 
 
Table 3. Composition of PEI/HA coated samples. 
 
Composition 
PEI 5% PEI 
PEI+HA 5% PEI + 2% HA 
 
5% PEI + 5% HA 
PEI + DETA 5% PEI + 0.3% DETA 
PEI + DETA + HA 5% PEI + 0.3% DETA + 2% HA 
 
5% PEI + 0.3% DETA + 5% HA 
 
 
Table 4. Composition of PCL/HA coated samples. 
 Composition 
PCL 5% PCL 
PCL + HA 5% PCL + 5% HA 
 10% PCL + 5% HA 
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MG-63 cells were cultured over these surfaces for periods up to 4 days in standard 
tissue culture conditions. Cell response was evaluated for viability/proliferation, 
morphology and F-actin cytoskeleton organization, by biochemical methods and 
observation by scanning electron microscopy (SEM) and confocal laser scanning 
microscopy (CLSM). Cells seeded in standard culture plates were used as control. 
 
3.2 Indirect cytocompatibility assays  
An indirect assay was used to analyse the cytocompatibility of (i) AZ31 alloy, (ii) 
anodised AZ31 alloy, and (iii) anodised AZ31 alloy coated with PCL containing 
2%HA. Cell response was addressed using human mesenchymal stem cells, human 
osteoclast precursors and human umbilical vein endothelial cells. Cells were cultured in 
appropriate experimental conditions for each cell type, in the presence of a 
concentration range of the extracts from the tested materials.  
Cell response was evaluated for viability/proliferation, morphology and phenotype 
markers. Cells cultured in the absence of the extracts were used as control. 
 
3.3 Effects of Mg ion on the osteoblastic, osteoclastic and endothelial cell 
response 
A range of Mg concentrations was used to analyse effect of Mg ion on osteoblastic, 
osteoclastic and endothelial cell response. Cell response was addressed using human 
mesenchymal stem cells, human osteoclast precursors and human umbilical vein 
endothelial cells. Cells were cultured in appropriate experimental conditions for each 
cell type, in the presence of a concentration range of the Mg ion, in the form of MgCl2. 
The Mg ion concentrations evaluated were: 1, 10, 20, 50 and 100mM. 
Cell response was evaluated for viability/proliferation and phenotype markers. Cells 
cultured in standard conditions were used as control. 
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3.4 Mg alloys 
The alloys used in this work were purchased from Goodfellow, Inc. The nominal 
composition of the alloy is depicted in Table 5. 
 
Table 5. Nominal chemical composition of the tested magnesium alloys. 
Elements Aluminium Zinc Manganese Rare Earth Zirconium Magnesium 
AZ31 2.5-3.5% 0.7-1.3% 0.2-1.0% - - Balanced 
AZ61 5.5-6.5% 0.2-1.0% 0.1-0.4% - - Balanced 
RZ5 - 3.5-5.0% 0.15% 0.8-1.7% 0.4-1.0% Balanced 
 
 
3.5 Substrate preparation 
The substrates used in this work were commercial AZ31 Mg alloy, AZ61 Mg alloy 
and RZ5 Mg alloy, with 3.8 cm2, that were mechanically polished with 2100 grit SiC 
paper. The coupons were degreased in alcohol and pre-treated by immersion in a 12% 
HF solution for 1 h. 
 
3.6 Anodisation: PEO 
Anodisation of AZ31 and RZ5 alloys was performed in a two-stage process: KOH 
100g/L + Na3PO4 100g/L (DC current 5.2A/dm2, voltage up to 30V, 10min, 20-25 ºC); 
KOH 6g/L + NaF 13g/L (DC current 3.7-1.5 A/dm2, voltage up to 180V, 10 min, 20-25 
ºC), according to the previously reported [124]. 
 
3.7 Coating formulation: PEI 
The polymeric coating was synthesized by mixing PEI in N,N-dimethylacetamide 
(DMAc), as a solvent, in concentrations of 15 wt.%. The mixture was stirred for 24 h at 
50 ºC in order to obtain a stable and yellowish but transparent solution. 
Diethylenetriamine (DETA) (3 wt.%) was added to this formulation. To improve the 
biocompatibility, nanohydroxyapatite particles (HA) were added to the obtained 
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solution in different percentages (2 and 5 wt.%). Detailed description of the 
methodology was previously reported [55]. 
The composite polymeric coating was applied on the metallic coupons using a dip 
coater and then it was cured in an oven at 150 ºC for 2 h under atmospheric conditions. 
The composite polymeric coating was also applied to glass coverslips. 
Several coating compositions were tested on glass coverslips: PEI, PEI + 2% HA, 
PEI + 5% HA, PEI + DETA, PEI + DETA + 2% HA and PEI + DETA + 5% HA (Table 
3). The best compositions were applied over AZ31 alloys. 
 
3.8 Coating formulation: PCL 
The coating system was composed of two layers applied in separated steps. Firstly, a 
polymeric layer was synthesized by mixing PEI in N,N-dimethylacetamide (DMAc), as 
a solvent, in concentrations of 2.5 wt.%. The polymeric coating was applied on the 
metallic coupons using a dip coater and then it was cured in an oven at 150 ºC for 2 h 
under atmospheric conditions. The second polymeric layer was prepared by dissolving 
PCL granules (Mn 70,000–90,000 Da) in chloroform, under magnetic stirring for 2 h. 
The composite polymeric coating was also applied to glass coverslips. 
Nanohydroxyapatite particles were added to the obtained solution. The PCL coatings 
were applied over the PEI-coated metallic coupons by dip coating. Detailed description 
of the methodology was previously reported [56]. 
Several coating compositions were tested on glass coverslips and over AZ31 alloys: 
5% PCL, 5% PCL+5% HA and 10% PCL+5% HA (Table 4). 
 
3.9 Extract preparation 
Samples of AZ31, anodised AZ31 and anodised AZ31 coated with 
PEI+DETA+2%HA, with 2 cm3, were incubated in 10 mL of culture medium (α-MEM 
or M199, depending of the cell culture tested) for 24h at 37ºC. After the incubation 
period, the medium was collected and a series of concentrations, between 50% and 2%, 
were added to cell cultures. Cultures of hMSC, PBMC and HUVECs were analysed for 
relevant phenotypic characteristics. 
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The concentrations of Mg and Ca ions in the pure extracts were analysed by atomic 
absorption spectroscopy, and are depicted in Table 6. pH values were measured with pH 
indicator stripes and are depicted in Table 6. The pH value of the medium with the 
extract concentrations used was 7.4, with the exception of the concentration 50% for the 
AZ31 and anodised samples (pH values = 7.8). 
 
Table 6. Concentration of Mg and Ca ions in the pure extracts (mM). 
  
Control a) AZ31 Anodised AZ31 
Anodized AZ31, coated 
PEI+DETA+2%HA 
Mg α-MEM 0.92±0.01 21.08±0.14 13.18±0.20 1.18±0.01 
 M199 0.97±0.01 17.04±0.25 13.76±0.10 4.21±0.04 
Ca α-MEM 1.62±0.01 1.37±0.01 1.18±0.04 1.81±0.01 
 M199 1.78±0.03 1.19±0.01 1.03±0.02 1.63±0.02 
pH α-MEM 7.4 9.5 8.5 7.4 
 M199 7.4 9.5 8.5 7.4 
a) Control is the culture medium used to prepare the extract. 
 
 
3.10 Cell cultures 
 
3.10.1 MG-63 cell cultures 
Human osteosarcoma MG-63 cells (ATCC) were cultured in standard culture 
conditions, i.e. α-minimal essential medium (α-MEM) containing 10% fetal bovine 
serum (FBS; Gibco/BRL), ascorbic acid (50 μg/mL), 2.5 μg/mL fungizone, penicillin-
streptomycin (100 IU/mL and 100 μg/mL, respectively), and incubated in a humidified 
atmosphere of 5% CO2 in air at 37ºC. 
At 70 to 80% cell confluence, adherent cells were enzymatically released with a 
solution of 0.05% trypsin in 0.25% EDTA to detach adherent cells, and the culture 
plates were incubated at 37ºC in a humidified atmosphere (5% CO2 in air) for 5 
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minutes. Complete culture medium (2 mL) was added to the culture plates to stop the 
enzymatic reaction. 
MG-63 cells were used in the direct cytocompatibility assays. Cells were cultured at 
a density of 105 cell/cm2 over (i) naked AZ31, AZ61 and RZ5 alloys and (ii) anodised 
AZ31 and RZ5 alloys. Samples were evaluated throughout 4 days, at two times points 
(day 1 and day 4). Evaluation of the cell cultures was performed for cell 
viability/proliferation (MTT assay) and observation by Confocal Laser Scanning 
Microscopy (CLSM) and Scanning Electron Microscopy (SEM). 
Also, cells were cultured at a density of 5x104 cell/cm2 over several compositions of 
PEI/HA coated AZ31 alloy and several compositions of PCL/HA coated AZ31 alloy. 
The cultures were evaluated throughout 4 and 5 days, respectively. The cell response to 
PEI/HA coatings was analysed for viability/proliferation (MTT assay) and observation 
by CLSM and SEM. Cell response to PCL/HA coatings was assessed for cell 
viability/proliferation (rezasurin assay), alkaline phosphatase (ALP) activity, and 
observation by CLSM and SEM. 
Cells seeded in standard culture plates were used as control for all groups analysed. 
 
3.10.2 Human mesenchymal stem cell cultures 
Human mesenchymal stem cells (hMSC, Lonza) were expanded on cell culture 
plates with α-minimal essential medium (α-MEM) containing 10% fetal bovine serum 
(FBS; Gibco/BRL), 2.5 μg/mL fungizone, penicillin-streptomycin (100 IU/mL and 100 
μg/mL, respectively), and incubated in a humidified atmosphere of 5% CO2 in air at 
37ºC. Third-subculture cells were used in the experiments. 
Human MSCs were cultured in the presence of 10 mM β-glycerophosphate and 10 
nM dexamethasone for the induction of the osteoblastic phenotype [125]. Cells were 
seeded at 104cells/cm2 in standard tissue culture plates. After 24h, the culture medium 
was removed and replaced by one containing the extracts from several Mg-based 
materials. Cultures were exposed to the extracts during 21 days, and the extract was 
renewed at each medium change (once a week). 
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Cell behaviour was analysed throughout the culture time for viability/proliferation 
(MTT assay, DNA content), ALP activity, expression of osteoblastic genes, 
histochemical staining of ALP and collagen and intracellular signalling pathways. 
 
3.10.3 Human osteoclastic cell cultures 
Peripheral blood mononuclear cells (PBMC) were isolated from blood of 25-35 
years old healthy male donors, after informed consent, as previously described [126]. 
Shortly, after dilution with phosphate-buffered saline (PBS) (2:1), blood was applied on 
top of Ficoll-Paque™ PREMIUM (GE Healthcare Bio-Sciences). Samples were 
centrifuged at 400 g for 30 minutes and PBMC were collected at the interface between 
Ficoll-Paque and PBS. Cells were washed twice with PBS. On average, for each 90 mL 
of processed blood about 450x106 PBMC were obtained. 
PBMC were seeded at 1.5x106cells/cm2 in standard tissue culture plates and cultured 
in α-MEM supplemented with 30% human serum (from the same donor from which 
PBMC were collected), 2.5 μg/mL fungizone, penicillin-streptomycin (100 IU/mL and 
100 μg/mL, respectively), 2 mM L-glutamine and the osteoclastogenic inducers M-CSF 
(25 ng/mL) and RANKL (40 ng/mL). After 24h, the culture medium was removed and 
replaced by one containing the extracts from several Mg-based materials. Cultures were 
exposed to the extracts during 21 days, and the extract was renewed at each medium 
change (once a week).  
Cell behaviour was analysed throughout the culture time for DNA content, Tartrate-
resistance acid phosphatase (TRAP) activity, expression of osteoclastic genes, caspase 
activity, histochemical staining of TRAP-positive multinucleated cells and intracellular 
signalling pathways. 
 
3.10.4 Human umbilical vein endothelial cell cultures 
Human umbilical vein endothelial cells (HUVECs, Lonza) were seeded in culture 
plates coated with 0.2% gelatine. Cultures were maintained in culture medium M199 
with 20% of FBS, 2.5 μg/mL fungizone, penicillin-streptomycin (100 IU/mL and 100 
μg/mL, respectively) and endothelial cell growth supplement (ECGS). Third subculture 
cells were used in the experiments. 
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Cells were seeded at 104cells/cm2 in culture plates coated with 0.2% gelatine. After 
24h, the culture medium was removed and replaced by one containing the extracts from 
several Mg-based materials. Cultures were exposed to the extracts during 7 days, and 
the extract was renewed at each medium change (every 3 days). Cell behaviour was 
analysed during the culture time for viability/proliferation (MTT assay, DNA content), 
caspase activity, NO concentration, expression of endothelial genes and tube-like 
formation assay. 
 
 
3.11 Cell viability/proliferation (MTT assay) 
The MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5,diphenyltetrazolium) assay is a method 
used to evaluate the viability, proliferation and activation of cells. This method is based 
in the capability of mitochondrial dehydrogenase, in live cells, to transform the MTT in 
a dark blue formazan product. 
MTT (0.5 mg/mL) was added to each well, and the culture plates were incubated for 
3 h at 37ºC. After the incubation period, the culture medium was removed; the formazan 
salts were dissolved in 100 μL of dimethylsulphoxide (DMSO) and the absorbance was 
determined at λ = 550 nm on a ELISA reader (Synergy HT, Biotek). Results were 
expressed as Absorbance per cm2 (Abs/cm2). 
In order to exclude the interference of magnesium ions in the MTT analysis, 
material samples without seeded cells were incubated in the same experimental 
conditions as the seeded materials and used as blank controls. 
 
3.12 Cell viability/proliferation (Rezasurin assay)  
In the resazurin assay, a non-fluorescent blue component is reduced by the living 
cells to a pink fluorescent component. At each time-point, the culture medium was 
removed, and fresh medium with 10% (v/v) of resazurin was added to the cells. 
Cultures were incubated at 37 °C in humidified atmosphere of 95% air and 5% CO2 for 
3 h. Then, 100 μL was transferred to a 96-well plate and the fluorescence intensity was 
measured in a microplate reader (Synergy HT, BioTek, USA) at 535nm excitation 
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wavelength and 590nm emission wavelength. The results were expressed in relative 
fluorescence units.  
 
3.13 DNA content assay 
DNA content assay was performed using Quant-iT™ PicoGreen ® dsDNA kit 
(Invitrogen, Molecular Probes) according to manufacturer’s instructions. Previously, 
cultures were treated with 0.1% Triton X-100 for 15 min. Fluorescence was measured 
on a ELISA reader (Synergy HT, Biotek, USA) at wavelengths of 480/520 nm 
(excitation/emission). 
 
3.14 F-actin cytoskeleton labelling 
Cells were fixed with formaldehyde (methanol free), for 15 min, and were washed 
twice with PBS. Cells were maintained at 4ºC in PBS until labelling. 
For labelling, cells were permeabilized with 0.1% triton in PBS, for 5 min. A 
solution of 10 mg/mL of BSA with 1 μg/mL RNAse in PBS was added and left in 
incubation for 1 h. A solution of 5 U/mL Alexa Fluor® 647-Phalloidin (Invitrogen, 
Barcelona, Spain) was added and cells were incubated for 20 min in the dark. Cells 
were washed with PBS, and a solution of propidium iodide (10 μg/mL in PBS; Sigma-
Aldrich, St. Louis, MO) was added. Cells were incubated for 10 min in the dark, at 
room temperature. Cells were washed with PBS, and maintained in a mounting medium 
(20 mM tris pH 0.8, 0.5% N-propyl gallate, 90% glycerol) before CLSM observation. 
CLSM was performed in a Laser Scanning Confocal Microscope Leica SP2 AOBS SE 
(Leica Microsystems, Germany). 
 
3.15 Scanning electron microscopy 
For SEM observation, cells were fixed with 1.5% glutaraldehyde in 0.14M sodium 
cacodylate buffer (pH 7.3). Then, samples were dehydrated in graded alcohols (70%, 
80%, 90%, 90% and 100%) for 10 minutes each. To simulate the critical point drying, a 
solution of hexamethyldisilazane (50%, 60%, 70%, 90% and 100%) in alcohol was 
added to the samples for 10 minutes each. Samples were sputter-coated with gold and 
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analysed in a scanning electron microscope (FEI Quanta 400FEG scanning electron 
microscope equipped with EDS microanalysis capability, EDAX Genesis X4M). 
 
3.16 ALP activity 
ALP activity of hMSC cultures was evaluated in cell lysates (0.1% Triton X-100, 5 
min) by the hydrolysis of p-nitrophenyl phosphate in alkaline buffer solution (pH≈10.3; 
30min, 37 ºC) and colorimetric determination of the product (p-nitrophenol) at 400 nm 
in an ELISA plate reader (Synergy HT, Biotek). ALP activity was normalized to total 
protein content (quantified by Bradford's method) and was expressed as 
nmol/min·μg	
 . 
 
3.17 TRAP activity 
TRAP activity of osteoclastic cell cultures was evaluated in cell lysates (0.1% Triton 
X-100, 5 min) by the hydrolysis of p-nitrophenyl phosphate in a acid buffer solution 
(pH = 5.8, 1 hour, 37ºC) and colorimetric determination of the product (p-nitrophenol) 
at 400 nm in an ELISA plate reader (Synergy HT, Biotek). TRAP activity was 
normalized to total protein content (quantified by Bradford's method) and was expressed 
as nmol/min·μg	
 . 
 
3.18 Total RNA extraction and RT-PCR analysis 
Osteoblastic, osteoclastic and endothelial cell cultures were characterized for the 
expression of important genes (Table 7), by RT-PCR. Total RNA was extracted using 
the Nucleospin RNA II kit (Machery-Nagel), according to the manufacturer’s 
instructions. RNA was analysed for its concentration and purity in each sample by UV 
spectrophotometry at 260 nm and by calculating the A260nm/A280nm ratio, 
respectively. RT-PCR was done using the Titan One Tube RT-PCR System (Roche 
Applied Science), according to the manufacturer’s instructions. Half microgram of total 
RNA from each sample was reverse transcribed and amplified (35 cycles) with Titan 
One Tube RT-PCR System (Roche), with an annealing temperature of 55ºC. The 
amplification conditions were chosen accordingly to preliminary calibration 
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experiments (data not shown), in order to become possible to use the RT-PCR analysis 
as a quantitative tool. RT-PCR products were separated on a 1% (w/V) agarose gel and 
gel band intensities were analysed with ImageJ 1.41 software. Values were considered 
as a percentage of the corresponding GAPDH (housekeeping gene) value of each 
experimental condition. 
 
Table 7. Primers used on RT-PCR analyses. 
Gene 5’ Primer 3’ Primer 
Housekeeping gene 
GAPDH CAGGACCAGGTTCACCAACAAGT GTGGCAGTGATGGCATGGACTGT 
Osteoblastic genes 
ALP ACGTGGCTAAGAATGTCATC CTGGTAGGCGATGTCCTTA 
Runx-2 CAGTTCCCAAGCATTTCATCC TCAATATGGTCGCCAAACAG 
Col-1 TCCGGCTCCTGCTCCTCTTA ACCAGCAGGACCAGCATCTC 
BMP-2 GACGAGGTCCTGAGCGAGTT GCAATGGCCTTATCTGTGAC 
OPG AAGGAGCTGCAGTACGTCAA CTGCTCGAAGGTGAGGTTAG 
Osteocalcin CATGAGAGCCCTCACA AGAGCGACACCCTAGAC 
Osteoclastic genes 
c-src AAGCTGTTCGGAGGCTTCAA TTGGAGTAGTAGGCCACCAG 
TRAP ACCATGACCACCTTGGCAATGTCTC ATAGTGGAAGCGCAGATAGCCGTT 
Ca2 GGACCTGAGCACTGGCATAAGGACT AAGGAGGCCACGAGGATCGAAGTT 
Catk AGGTTCTGCTGCTACCTGTGGTGAG CTTGCATCAATGGCCACAGAGACAG 
Endothelial genes 
VE-cadherin GAGTGGCAAGAATGCCAAGT TACTTGGTCATCCGGTTCTG 
CD31 ATGAAGAGCCTGCCGGACTG TTCCGTCACGGTGACCAGTT 
VWF TCGGAAGTGACTTCGTCAAC AACACCCAGGTGCTCTTCAG 
 
 
3.19 Caspase activity 
Caspase-3 is a protease that has been found to have an important role in the 
initiation of apoptosis. This caspase has a substrate specificity to the amino sequence 
Asp-Glu-Val-Asp and cleaves several proteins, such has poly(ADP-ribose) polymerase, 
(PARP) and DNA-dependent protein kinase [127]. Caspase activity was performed 
using EnzCheck caspase-3 assay kit #2 (Invitrogen, Molecular Probes) according to 
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manufacturer’s instructions. Previously, cultures were treated with 0.1% Triton X-100 
for 15 min. Fluorescence was measured on a ELISA reader (Synergy HT, Biotek, USA) 
at wavelengths of 496/520 nm (excitation/emission). ). Caspase-3 activity was 
normalized to total protein content (quantified by Bradford's method) and was expressed 
as nmol/min·μg	
 . 
 
3.20 Histochemical staining of TRAP-positive multinucleated cells 
At days 7, 14 and 21 of culture, osteoclastic cell cultures were fixed in 3.7% 
formaldehyde for 10 min. Cells were rinsed with distilled water and stained for TRAP 
and Acid Phosphatase, Leukocyte (TRAP) kit (Sigma), according to manufacturer’s 
instructions. TRAP-positive (dark red/purple) and multinucleated cells were counted in 
a microscope (Nikon TMS inverted phase microscope). 
 
3.21 Histochemical staining of ALP 
At days 7, 14 and 21 of culture, hMSC cultures were fixed in 1.5% glutaraldehyde in 
sodium cacodilate (0.14M) for 10 min. Cells were rinsed with PBS and stained with a 
solution of α-napthyl acid phosphate (2mg/mL) and Fast Blue R (2mg/mL) prepared in 
Tris 0.1M, pH 10. The cultures were incubated for 1h in the dark and washed with water 
at the end of the period. The presence of ALP was noticed by a brown to black staining 
according to the relative amount of the enzyme. The presence of the staining was 
assessed under a Nikon TMS inverted phase microscope. 
 
3.22 Histochemical staining of Collagen 
At days 7, 14 and 21 of culture, hMSC cultures were fixed in 1.5% glutaraldehyde in 
sodium cacodilate (0.14M) for 10 min. Cells were rinsed with PBS and stained with a 
solution of 0.1% Sirius red F3BA in saturated picric acid. The cultures where incubated 
for 1h and washed with 0.01N HCl at the end of the period. The presence of collagen, a 
pink staining, was assessed under microscope (Nikon TMS inverted phase microscope). 
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3.23 Signalling pathways 
Osteoblastic and osteoclastic cultures exposed to 10% of extracts, Mg ion 
concentration and control cultures were analysed for intracellular signalling pathways 
involved in osteoblastogenesis and osteoclastogenesis. Cultures performed as previously 
described were exposed to signalling pathways inhibitors throughout the culture time. 
At day 14, osteoblastic and osteoclastic cultures were analysed for ALP and TRAP 
activity, respectively. The signalling pathways inhibitors used were: 1 μmol/L U0126 
(MEK signalling pathway inhibitor), 10 μmol/L PDTC (NF-kB signalling pathway 
inhibitor), 10 μmol/L SP600125 (JNK signalling pathway inhibitor) and 5 μmol/L 
SB202190 (p38 MAPK signalling pathway). Results were presented as percentage of 
variation of ALP or TRAP activity relative to the sample in the absence of the inhibitor. 
 
3.24 In vitro tube-like formation assay: the Matrigel assay 
The ability of endothelial cell cultures in organizing the cell layer in a network of 
tube-like structures upon the contact with an extracellular matrix was evaluated using 
the Matrigel assay. Endothelial cell cultures were performed as described above. At day 
4 of culture, the medium was removed and 10mg/mL of Matrigel (BD Matrigel Matrix, 
BD Biosciences, Franklin Lakes, New Jersey, USA) was added to the culture. After an 
incubation of 60 min, at 37ºC, for the jellification of the matrix, culture medium was 
added to the wells and cultures kept for 24h. Capillary tube-like formation was assessed 
under a microscope (Nikon TMS Inverted Phase microscope). 
 
3.25 Chick chorioallantoic membrane (CAM) assay 
The effect of the extracts from the Mg-based substrates in the in vivo angiogenic 
response was evaluated by the CAM assay. Fertilized chicken embryos were incubated 
at 37ºC in 45% humidity for 4 days. After this period, a hole was drilled in order to 
expose the vascular zone of the embryo. A sterilized filter-paper disk, used as carrier for 
Mg extracts, was applied to the vascular zone. The eggs were sealed and incubated for 3 
days at 37ºC. After the incubation period, the number of blood vessels surrounding the 
discs was photographed (Nikon TMS Inverted Phase microscope) and counted. 
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3.26 Statistical analysis 
Four independent experiments were performed in all biological assays. In each 
experiment, three replicas were accomplished for the quantitative assays and two 
replicas for the qualitative assays. The results are shown as mean ± standard error (± 
SE). Data were analysed with one-way analysis of variance (ANOVA). Statistical 
differences were determined by the post hoc Tukey HSD multicomparison test. A p 
value of value of ≤ 0.05 was considered statistically significant. 
 
  
 
 
 
 
Chapter 4 
Direct cytocompatibility assays 
Osteoblastic cell behaviour over the Mg-based substrates 
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The development of magnesium alloys suitable for biodegradable implants is 
dependent on the control of corrosion rate and mechanical integrity of the implant in 
physiological environment. An approach to control corrosion rate is thus surface 
treatment of the alloys. These treatments are interesting for degradable implants because 
the corrosion rate is intended to be low in the initial phase due to the modified surface 
layer and then returns to the normal value when the layer corrodes away [57]. Such 
degradation pattern is desirable since the loss of strength of the implant would mirror 
the increase in strength of the healing bone, providing sufficient support in the initial 
phase [57]. 
In this work, several approaches were used to control corrosion rate of Mg alloys. 
Firstly, the cytocompatibility of three Mg alloys, AZ31, AZ61 and RZ5 was analysed to 
evaluate the best Mg alloy to be used in the surface treatments. In a second part, a 
surface modification by anodisation was used to increase the corrosion resistance of the 
two alloys with the best performance, AZ31 and RZ5. Furthermore, two polymeric 
coatings, based on PEI and PCL, used alone or containing nanohydroxyapatite particles, 
were also evaluated. Firstly, the cytocompatibility of several coatings’ compositions 
was analysed by them self, i.e. applied onto a glass surface, thus without the 
interference of an underlying Mg alloy. Subsequently, the best coatings’ compositions 
were applied to Mg alloy AZ31 and the resulting substrates were analysed for their 
cytocompatibility. 
The cytocompatibility of these surface treatments was evaluated using MG-63 
osteoblastic cell cultures. 
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4.1 Osteoblastic cytocompatibility of AZ31, AZ61 and RZ5 Magnesium 
alloys 
 
AZ31, AZ61 and RZ5 alloys have magnesium as their major component; the 
additional alloying materials vary in presence and concentration. The second element in 
AZ31 and AZ61 alloys is aluminium, whereas RZ5 alloy have a higher percentage of 
zinc. RZ5 alloy also presents rare earth metals such as cerium and lanthanum. The 
composition of the alloys was presented in Table 5. 
To analyse the cytocompatibility of the alloys, MG-63 cells were seeded on the 
surface of the materials and the colonized materials were cultured for 1 and 4 days. Cell 
behaviour was evaluated throughout the culture time for viability/proliferation (MTT 
assay) and SEM observation to assess the cell morphology, pattern of cell growth and 
distribution on the material surface and cell/surface interactions. Cultures performed on 
the standard tissue culture plates were used as control. 
Results for the viability/proliferation are shown in Figure 3. Control cultures 
presented an increase in viability/proliferation during the culture period. The 
magnesium alloys showed a significantly reduced viability/proliferation compared to 
control. A similar number of cells attached to the three alloys, as suggested by the 
identical MTT reduction values at day 1. On AZ31 and RZ5 alloys, cell proliferation 
increased from day 1 to day 4, especially on AZ31 alloy. However, AZ61 presented a 
higher toxicity, which increased with the culture time, as seen by the lower values at 
day 4 compared to those at day 1.  
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Figure 3. Viability/proliferation of MG-63 osteoblastic cells seeded on magnesium 
alloys, AZ31, AZ61 and RZ5. * Significantly different from control cultures (MG-63 
cells cultured in standard tissue culture plates). 
 
 
SEM observation was performed on control cultures and on the colonized alloys, at 
days 1 and 4, Figure 4. At day 1, control cultures presented cells with an elongated 
morphology, characteristic of this cell type, and cell-to cell contact. On AZ31 and RZ5 
alloys, cells also exhibited an elongated morphology, but cytoplasmic expansion was 
lower than that on control cells, suggesting some degree of cytotoxicity. AZ61 showed 
only few cells with a round morphology, evidencing a high cytotoxicity of this alloy 
which did not allow the process of cytoplasmic expansion/cell spreading after the cell 
adhesion. At day 4, control cultures exhibited a well-organized and dense cell layer. 
AZ31 and RZ5 alloys also allowed the formation of a cell layer, although with a lower 
density compared to the control cultures. However, cells cultured on RZ5 alloy showed 
evident morphological alterations, mainly a reduced cytoplasmic volume, compared to 
those on AZ31 alloy and control cultures. Similar to that observed in the MTT assay, 
AZ61 alloy presented a high toxicity; at day 4, cells were barely observed on the 
material surface. 
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Figure 4. Representative SEM images of MG-63 osteoblastic cells seeded on AZ31, 
AZ61 and RZ5 alloys. Yellow marks correspond to spots with cells. Bar: 200 μm. 
 
 
The alloys showed fragmentation of the material surface with evident 
corrosion/dissolution processes occurring after incubation with culture medium (Figure 
5). This was evident particularly in AZ61 which presented a higher fragmentation rate, 
even at day 1. AZ31 and RZ5 were further analysed before and after incubation with 
culture medium. The EDS analysis showed an increase of carbon, oxygen and 
phosphate after incubation with culture medium for four days. 
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Figure 5. Representative SEM images and respective EDS analysis of AZ31 and RZ5 
alloys, before and after contacting with the cell culture medium, for 4 days. Bar: 20 μm. 
 
CLSM observation was in agreement with the information provided by SEM. 
Control cultures presented an organized cell layer, with extensive cell-to-cell contact by 
day 4 (Figure 6). Cultures on alloys presented a lower amount of cells. Cells seeded in 
AZ61 alloy showed rounded morphology on day 1, and by day 4 they were barely 
visible. AZ31 and RZ5 had a better performance compared to AZ61. In these two 
alloys, cells with a normal adhesion, elongated morphology and spreading events were 
observed at day 1. At day 4, a cell layer was observed on both alloys. 
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Figure 6. CLMS observation of MG-63 osteoblastic cells seeded on magnesium alloys, 
stained for F-actin cytoskeleton (green) and nucleus (red). Bar: 80 μm. 
 
The three alloys studied in this work presented a lower performance compared to 
control cultures. When comparing the alloys, AZ61 Mg alloy showed the highest 
toxicity in all tests performed. AZ31 and RZ5 alloys presented better cytocompatibility. 
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4.2 Osteoblastic cytocompatibility of anodised AZ31 and RZ5 alloys 
 
Anodisation is one of the methods used to control corrosion of Mg alloys, which 
consist in the formation of a thick film on the surface of the alloy. In this study, 
anodisation of AZ31 and RZ5 alloys was performed using plasma electrolytic oxidation 
(PEO). PEO is a two-way process using different electrolytes (KOH+Na3PO4; 
KOH+NaF) and different current densities. The anodic layer formed on the magnesium 
alloys exhibited a bi-layer containing an inner barrier layer composed of magnesium, 
oxygen, phosphorous and fluoride and a porous external layer containing essentially 
magnesium oxide [124]. 
To analyse the biocompatibility of the anodised AZ31 and RZ5 alloys, MG-63 cells 
were seeded on the surface of the materials and the behaviour was evaluated at day 1 
and day 4. Cell response was assessed for viability/proliferation and SEM and CLSM 
observation. 
Figure 7 shows the results for the viability/proliferation, assessed by the MTT assay. 
Control cultures presented an increase in viability/proliferation during the culture 
period. MG-63 cells seeded on the anodised alloys also presented an increase in 
proliferation from day 1 to day 4. However, compared to control culture, the 
viability/proliferation was significantly lower for both materials. Between the two, no 
significant differences were observed.  
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Figure 7. Viability/proliferation of MG-63 osteoblastic cells seeded on anodised AZ31 
and RZ5 alloys. * Significantly different from control cultures (MG-63 cells seeded in 
standard tissue culture plates). 
 
Figure 8. Representative SEM images of MG-63 osteoblastic cells seeded on anodised 
AZ31 and RZ5 alloys. Yellow arrows correspond to spots with cells. Bar: 200 and 50 
μm. 
 
 
On SEM observation, Figure 8, control cultures presented an organized cell layer 
which increased with the culture time; cells exhibited the typical elongated morphology 
expected for this cell type. The alloys presented a significantly lower number of cells, 
compared to control, both at days 1 and 4. However, high magnification SEM images 
showed that cells were able to adapt to the irregular surface topography and, in addition, 
presented an elongated morphology with an appropriate cytoplasmic expansion, 
suggesting a healthy behaviour. 
Anodised AZ31 and RZ5 alloys were also analysed before and after incubation with 
culture medium, Figure 9. The surface of both alloys presented an intact appearance, 
without fracture or visible evidence of corrosion. The EDS analysis showed an increase 
of carbon, oxygen, phosphate and calcium after incubation with culture medium for four 
days. 
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Figure 9. Representative SEM images and respective EDS analysis of anodised AZ31 
and RZ5 alloys, before and after contacting with the cell culture medium. Bar: 20 μm. 
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Figure 10. CLMS observation of MG-63 osteoblastic cells seeded on anodised alloys, 
stained for F-actin cytoskeleton (green) and nucleus (red). Bar: 80 μm and 40 μm. 
 
CLMS observation showed similar results to the ones observed by SEM. MG-63 
cells were able to adhere to both anodised alloys, AZ31 and RZ5 (Figure 10). Cell 
cultures presented normal adhesion and spreading events. Also, most cells showed an 
elongated morphology and proliferated during the culture period. 
Anodisation of Mg alloys created a surface capable of increasing the cell attachment 
and proliferation, compared to the bare alloy. However, cell growth rate was still lower 
when compared to control cultures. 
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4.3 Osteoblastic cytocompatibility of polyether imide-coated AZ31 alloy  
 
Polyether imide (PEI) is an amorphous polymer with good chemical and thermal 
stability, high mechanical strength, excellent membrane forming properties and can be 
easily modified by wet chemical processes [128,129,130,131]. PEI has shown to be 
non-toxic and a biocompatible substrate for cell proliferation in MG-63 cells [128] and 
human umbilical vein endothelial cells (HUVEC) [131,132]. PEI has also been 
described to increase the corrosion resistance of Mg alloys [133].  
In order to enhance the resistance and cytocompatibility of the polymeric coating, a 
variety of techniques can be used, including the addition of diethylenetriamine (DETA) 
and nanoparticles of HA. DETA is a cross-link agent which has been described to 
enhance adhesion of the polymer to the substrate and with a self-healing effect 
[134,135]. HA nanoparticles, which have a chemical composition similar to the 
inorganic part of the bone, have been described to enhance osteoblastic cell 
differentiation [136] and may act as a corrosion inhibitor [137]. 
In this work, a series of PEI coating compositions were analysed for their ability to 
influence in the cytocompatibility of MG-63 cells cultured on the surface of Mg alloys. 
Firstly, the cytocompatibility of a series of PEI compositions was analysed with the 
polymer applied over glass coverslips to discern the performance of the coating without 
the interference of the underlying Mg alloy. The compositions with the best 
performance were further analysed when applied on the surface of AZ31 Mg alloy. 
MG-63 cells were cultured at a density of 5x104 cell/cm2 on the surface of the 
coatings. Osteoblastic cytocompatibility of the coating, by itself and applied over 
magnesium alloys, was evaluated regarding cell adhesion and proliferation, and 
morphology. 
The following polymeric coating compositions were applied over glass coverslips: 
15%PEI; 15%PEI+2%HA; 15%PEI+5%HA; 15%PEI+0.3%DETA; 
15%PEI+0.3%DETA+2%HA; 15%PEI+0.3%DETA+5%HA (Table 3).  
Results for the viability/proliferation are depicted in Figure 11.  
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Figure 11. Cell viability/proliferation of MG-63 osteoblastic cells cultured on 
representative coating compositions applied over glass coverslips. *Significantly 
different from PEI. 
 
All coatings allowed the proliferation of the osteoblastic cells, as the values 
observed in the MTT assay increased from day 1 to day 4. Coatings containing HA (2% 
or 5%) and PEI+DETA presented lower values compared to PEI, although the 
differences did not attain statistical significance (Figure 11). However, the presence of 
HA (2% or 5%) in the coatings containing the crosslinking agent (DETA) greatly 
improved cell proliferation. This inductive effect was noted at day 1, and attained 
statistical significance at day 4. Cells cultured over standard coverslips presented MTT 
reduction values similar to those on PEI coating (Figure 11). 
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Figure 12. Representative SEM images of coating compositions applied over glass 
coverslips and seeded with MG-63 osteoblastic cells, at day 1. Cultures performed on 
control coverslips (e, f).  Bar: 200µm (a, c, e) and 50µm (b, d, f). 
 
SEM observation of the colonized coatings provided similar information. However, 
changes in the cell morphology were also noted. Cells attached to the PEI coating 
displayed a flat and spread appearance (Figure 12.a,b). Comparatively, on the PEI 
coatings containing HA, cells were elongated and with a more tridimensional structure 
(Figure 12.a,b). On the PEI+DETA coating, cells appeared elongated, but relatively 
thinner (Figure 12.c,d). Interestingly, cells attached on PEI+DETA coating containing 
HA (2% or 5%) also appeared elongated but with a higher volume (Figure 12.c,d). 
These observations suggest a healthier cellular morphology over the coatings containing 
HA. The best performance was achieved in the coatings with the crosslinking agent and 
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HA. At day 1, cells presented already cell-to-cell contact and a perfect adaptation to the 
underlying rough topography (Figure 12.c,d). At day 4, all coatings were covered with a 
cell layer, which appeared denser over PEI+DETA+HA coatings (Figure 13.a). The cell 
layer appeared relatively flat over PEI and PEI+DETA coatings, and with well-
organized cell clusters over the coatings containing HA (Figure 13.a,b). No significant 
differences were found between the coatings containing 2% or 5% HA, although the 
composition with 2%HA appeared to present an improved performance. The SEM 
appearance of the cells grown over standard coverslips was similar to that observed over 
the PEI coating, at day 1 (Figure 12.e,f) and at day 4 (Figure 13.c). 
 
 
Figure 13. Representative SEM images of coating compositions applied over glass 
coverslips and seeded with MG-63 osteoblastic cells, at day 4. Cultures performed on 
control coverslips (c).  Bar: 200μm (a, c) and 50μm (b). 
 
Cellular response over the coatings applied on the AZ31 Mg alloy was assessed by 
CLSM (day 1) and SEM (days 1 and 4). Cell morphology, pattern of cell growth and 
differences among the coatings were similar to those seen on the coatings applied over 
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the glass coverslips. Representative images are shown for the coatings PEI, 
PEI+DETA+2%HA and PEI+DETA+5%HA (Figure 14). 
 
 
Figure 14. Representative CLSM (a, b) and SEM (c) images of coating compositions 
applied over AZ31 alloy and seeded with MG-63 osteoblastic cells, at day 1 (a, b) and 
day 4 (c). Bar: 80μm (a), 20μm (b) and 50μm (c). 
 
At day 1, CLSM images (Figure 14.a, b), showed well spread cells with a prominent 
nucleus and cell-to-cell contact. In addition, a well-organized F-actin cytoskeleton 
(which stained intensively at the cell limits) was evident. However, cells adhered to 
PEI+DETA+5%HA displayed signs of toxicity, reflected by some shrinkage of the 
cytoplasm with a reduction in the cell volume and a higher number of cells with 
aberrant cytoskeleton organization and morphology than that seen on PEI and 
PEI+DETA+2%HA. The apparent signs of deleterious effects on the cytoskeleton 
detected over PEI+DETA+5%HA might be related to its lower corrosion performance 
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compared to the one containing 2%HA, as mentioned in Zomorodian et al. (2013) [55]. 
However, high magnification SEM images (Figure 14.c, day 4) show spread cells 
perfectly adapted to the coating topography in both HA-containing coatings. 
The PEI coatings analysed in this work were found to increase the cytocompatibility 
of AZ31 alloy. Furthermore, the incorporation of HA nanoparticles, especially at 2%, 
increased the osteoblastic compatibility of the PEI-based coatings. 
 
 
4.4 Osteoblastic cytocompatibility of polycaprolactone-coated AZ31 alloy  
 
Polycaprolactone (PCL) is a semicrystalline polyester with great organic solvent 
solubility and a melting temperature of 55 – 60 °C [138]. PCL is used in research and 
clinical applications and is approved by the Food and Drug Administration (FDA) as a 
biodegradable polymer [89]. It has been purposed for long-term implant device due to 
the low rate of degradation in vivo [138]. PCL has also been used as coating for 
magnesium alloys presenting promising results, decreasing corrosion rate and 
augmenting biocompatibility of the alloys [10].  
In this work, a PCL coating was produced to prolong the corrosion resistance of 
AZ31 for long periods. To overcome the problem with adhesion of PCL coating to the 
substrate, an inner polyether imide (PEI) layer with a nanometric thickness was used as 
adhesion promoter between the AZ31 and the PCL coating. The following compositions 
were analysed: 5% PCL, 5% PCL+5% HA and 10% PCL+5% HA (Table 4). 
MG-63 cells were cultured at a density of 5x104 cell/cm2 on the surface of the 
coatings, and were analysed for up to 5 days. As a first approach, cell behaviour was 
addressed on the coatings applied onto glass coverslips, to have information on their 
performance without any interference of the AZ31 magnesium alloy. Subsequently, the 
coatings were applied onto the pre-treated Mg alloy and tested for the cellular response. 
Osteoblastic cytocompatibility of the coating was evaluated regarding cell adhesion and 
proliferation, morphology and ALP activity. 
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Results concerning cell viability/proliferation and ALP activity of the cultures 
grown on the three coatings’ compositions are depicted in Figure 15. All coatings, 
applied over the glass or over the pre-treated alloy, allowed the proliferation of the 
osteoblastic cells, as the values observed in the Resazurin assay increased from day 1 to 
day 5. 
 
 
Figure 15. Cell viability/proliferation (days 1 and 5) and Alkaline phosphatase activity 
(day 5) of MG-63 osteoblastic cells grown over the glass-coated samples and the AZ31-
coated alloy. *Significantly different from 5%PCL, for each condition (p≤0.5). 
 
On the glass coated samples, values were similar at day 1, suggesting the presence 
of a comparable number of viable cells over the three compositions. However, at day 5, 
the 5%PCL+5%HA coating showed increased values (~30%), as compared to the other 
compositions. Cultures grown over the coatings applied to the pre-treated alloy 
presented some differences on cell behaviour. At day 1, values from the Resazurin assay 
were identical to those measured on the glass coated surfaces, suggesting that cell 
adhesion behaves quite similar; also, no differences were noted among the three 
compositions. However, at day 5, values were lower on the coatings applied over the 
pre-treated alloy (~30%), and they were similar for the three compositions. 
Nevertheless, cultures grown over the coated glass or the coated pre-treated alloy 
showed similar ALP activity. Further, in both conditions, ALP activity was higher in the 
HA-containing coatings compared to the PCL matrix, but no significant differences 
were found between 5%PCL+5%HA and 10%PCL+5%HA. 
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Figure 16 depicts representative SEM and CLSM images of the cultures grown over 
the glass coated samples. At day 1, cells presented an elongated morphology on the 
three compositions. CLSM images show that cells stained for the F-actin cytoskeleton 
presented a higher staining intensity at the cell limits. They also exhibit a well-defined 
and developed nucleus; in addition, cells on on-going cell division were already visible. 
At day 5, the three coatings showed a higher number of cells, which appeared well 
spread over the 5%PCL coating and more elongated over the coatings containing HA. It 
is worth to note that there was a distinct pattern of cell distribution over the two HA-
containing coatings. 
 
 
Figure 16. Representative SEM and CLSM images of MG-63 osteoblastic cells cultured 
for 1 and 5 days over coatings applied on glass. On CLSM images, cells were stained 
for the F-actin cytoskeleton (green) and nucleus (red). 
 
On the 5%PCL+5%HA coating, cells were clearly more concentrated on the surface 
areas containing the HA micro-aggregates, whereas cells exhibited a relatively 
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randomly distribution over the 10%PCL+5%HA coating. In both coatings, cells 
appeared to adapt perfectly to the underlying surface topography. This pattern of cell 
growth was evident both in the low and the high magnification SEM images. Also, 
CLSM images provided similar information, i.e. cells were agglomerated in preferential 
areas on the 5%PCL+5%HA coating and were randomly distributed over the 
10%PCL+5%HA coating. 
 
 
Figure 17. Representative SEM images of MG-63 osteoblastic cells cultured for 1 and 5 
days over coatings applied on pre-treated AZ31 alloy. 
 
Figure 17 displays the morphology and pattern of cell growth over the coatings 
applied to the pre-treated AZ31 Mg alloy, as visualized by SEM. At day 1, cells 
presented an elongated appearance, similar to that observed over the glass coated 
samples. However, at day 5, some differences on the morphology were evident. On the 
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AZ31 coated samples, cells showed lower cytoplasmic spreading, on the three 
compositions. Nevertheless, they exhibited the same pattern of cellular distribution. On 
the 5%PCL+5%HA coating, they were concentrated on the coating locations containing 
the HA micro-aggregates, whereas they were randomly distributed over the 
10%PCL+5%HA coating. 
The several PCL coatings tested in this work were found to increase the 
cytocompatibility of Mg alloys. Furthermore, the addition of HA increased viability and 
the functional activity of MG-63 osteoblastic cells. 
 
 
4.5 Discussion 
 
Magnesium alloys have been suggested for biomedical applications, showing 
various advantages for bone tissue regeneration. Mg alloys can be used as 
biodegradable implants for their ability to corrode in physiological environment [44]. In 
this study, a set of techniques were used to control corrosion rate: alloy composition and 
surface treatments such has anodisation and polymeric coating. 
Initially, three commercially available magnesium alloys (AZ31, AZ61 and RZ5) 
were analysed for their osteoblastic cytocompatibility. The results showed reduced 
viability/proliferation over the Mg alloys compared to control cultures. Of the three 
alloys, AZ31 and RZ5 presented a better performance in vitro. These two alloys showed 
the formation of a cell layer throughout the culture time (observed by CLMS and SEM). 
In the literature, alloys such as Mg-Ca alloy [117] and AZ31 alloy [7] have shown 
similar results. MG-63 cells cultured on the surface of Mg-Ca alloy showed a decreased 
viability/proliferation in a 5 days culture period [117]. Furthermore, the same authors 
found a decreased ALP activity of the osteoblastic cells at 5 days of culture. Tan et al. 
(2010) reported a decreased viability/proliferation of MG-63 cells cultured in surface of 
AZ31 alloy for 48 hours, when compared to cultures in standard conditions i.e. seeded 
in culture plates [7]. 
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The fragmentation of the three alloys started immediately after incubation with 
culture medium, especially for AZ61 alloy. The decreased cell adhesion and 
proliferation observed over the Mg alloys could be strongly affected by changes 
occurring on the material surface as a result of the fast corrosion process. The 
phenomenon of corrosion of Mg alloys creates hydrogen gas, which forms bubbles in 
the surface of the material and increase the pH levels of the surrounding medium [4,51]. 
As a result of corrosion, a more dynamic surface is created, decreasing the cells’ ability 
to adhere and proliferate in such environments. Higher corrosion rate would also 
increase the amount of ions and debris in the culture medium, leading to a further 
damage of cells. Besides the increase of pH levels, it has been described alterations in 
the osmolality of the culture medium, increased concentration of Mg2+ and decreased 
levels of Ca2+ and PO43- [43,139]. These alterations could lead to more damage in the 
cells, particularly in the case of AZ61 which has a higher corrosion rate. 
The results showed a higher rate of degradation and corrosion in AZ61 alloy, 
compared to the other two alloys. A main difference between the three selected alloys is 
the alloying composition, which has been described as a major factor for alterations in 
the biocompatibility of magnesium materials [5]. AZ61 alloy has a higher concentration 
of aluminium compared to AZ31 alloy, whereas RZ5 alloy has higher percentage of 
zinc plus rare earth elements. Higher percentages of aluminium and zinc have been 
described to increase oxidation rate of magnesium alloys [33]. In Hank’s solution, 
AZ31 alloy has shown to have better corrosion resistance than AZ91 alloy (with higher 
concentration of aluminium) [67], which could explain the poorest outcome of AZ61 
alloy in this work. Also, Witte et al. (2005) described a better resistance to corrosion in 
alloys with rare earth elements (such as RZ5) [33]. Also, it has been described a better 
cellular response to magnesium-rare earth alloys when compared to pure magnesium, 
with a better attachment and spreading of endothelial cells in the magnesium-rare earth 
alloys [115]. 
Another option for controlling corrosion rate and therefore improving 
cytocompatibility of Mg alloys is through surface modification. In this work, 
anodisation by PEO was used to create an oxide layer, containing phosphorous and 
calcium. This layer decreased the amount of degradation of the magnesium alloys. This 
process provided a suitable environment for cells to attach and proliferate. Accordingly, 
it was possible to observe an increase in cell viability/proliferation in both anodised 
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alloys, AZ31 and RZ5. In addition, the results achieved for anodised alloys indicated a 
better surface and environment for cell attachment and growth, when compared to the 
base alloys. 
The results in this work are in accordance to the reports in literature. In vitro 
corrosion studies have shown that creating a layer composed of Ca-P can increase 
corrosion resistance and biocompatibility [51]. Keim and co-works (2011) reported that 
incubating the alloys prior the seeding of the cells, 24 hours in advance, created a 
protection layer of Ca-P in which cells are able to attach. Anodised alloys incubated in 
physiological environment also showed to be more resistant to corrosion 
[7,78,79,80,140]. AZ31 alloy has shown a better performance during immersion in 
physiologic environment after surface treatment by anodisation [9,81]. A factor that 
should be taking into consideration is the fact that corrosion rate of anodised alloys is 
dependent on the base material used [82]. Thus, if the base alloy is prone to high 
corrosion rate, the anodisation coating will be less effective as soon as the base material 
comes into contact with physiological environment. In a study performed by Pompa et 
al. (2015), AZ31B, AZ91E and ZK60A where evaluated for their biocompatibility after 
anodisation [119]. It was found that MC3T3 cells cultured in the surface of bare and 
anodised ZK60A presented a decreased viability. AZ31 and AZ91 showed an increase 
in viability of MC3T3 cell, especially in the anodised samples. Both samples had a 
higher corrosion resistance compared to ZK60A. 
In vitro studies have revealed that cells seeded in direct contact with the anodised 
alloys have better biocompatibility compared to uncoated alloy [7]. It is important to 
mention that, in vivo, alloys with/and without surface treatments have a better 
performance [141]. Park and co-workers (2012) reported a better response of anodised 
material compared to base alloy [100]. However, both alloys had good biocompatibility 
when implanted in rats; in addition, the implants were absorbed within weeks, and the 
absorption period increased in the anodised alloy. The same results were observed by 
Yang et al. (2011) using a rabbit model [52]. The coated implant was found to decrease 
the amount of hydrogen gas produced compared to uncoated sample. It was also 
observed a better performance in vivo in coated alloys, with evidence of slower 
degradation [52]. 
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Polymeric coatings, PEI and PCL, were also used to improve the cytocompatibility 
of AZ31 Mg alloy. As a first approach, cell behaviour was addressed in the coatings 
applied onto glass coverslips in order to obtain information on their performance 
without any interference from the underlying AZ31 Mg alloy. Subsequently, the 
coatings applied onto the Mg alloy were also tested for cellular response. 
A series of PEI-based coatings’ compositions were tested to analyse the effect of the 
several components of the coating: 15%PEI, 15%PEI+2%HA, 15%PEI+5%HA, 
15%PEI+0.3%DETA, 15%PEI+0.3%DETA+2%HA and 15%PEI+0.3%DETA+5%HA. 
Regarding the results from PEI coatings applied onto glass coverslips, it was found 
that adding DETA to PEI polymer did not contribute to a positive effect on cell 
response. It was observed a poorer performance of this coating compared to PEI by 
itself. The addition of HA to the polymeric coating did not affect the 
viability/proliferation compared to PEI coating. However, the combination of 
DETA+HA increased the viability/proliferation of MG-63 osteoblastic cells. 
Furthermore, on these coatings, cells presented a better morphology, showing a higher 
volume, compared to samples with only one of the two components. Additionally, the 
coatings with 2% of HA presented a better cell response. 
In the PEI coated AZ31 samples, a similar behaviour was observed, namely a better 
performance on the samples with a combination of DETA+HA. Also, a better 
performance was observed in the samples with 2% of HA. 
A series of PCL coatings were also tested: 5% PCL, 5% PCL+5%HA, 
10%PCL+5%HA. Firstly, the coatings were tested in glass coverslips to analyse the 
effect of the various coatings without the interference from Mg alloy. The 
viability/proliferation increased in all coatings tested throughout the culture period. At 
day 5, a significant increase in viability/proliferation was observed in the coating 
5%PCL + 5% HA. The functional activity of the two coatings with HA particles 
significantly increased when compared to PCL by itself. 
The AZ31 coated samples also showed a better performance compared to naked 
samples. When comparing the three coatings tested, the results showed no significant 
differences in the viability/proliferation, although ALP activity and morphology were 
better in the samples with HA particles. 
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The cell behaviour was greatly improved in both polymeric coatings with HA 
particles. This improvement was evident in viability assays, cell morphology and, 
especially, in the results regarding ALP activity. In PCL coating, ALP activity was 
significantly higher on both HA-containing coatings. ALP is an important enzyme 
produced by osteoblastic cells from the early stages of the osteoblastic commitment, and 
is actively involved in the mineralization of the extracellular matrix, by providing 
phosphate ions from the hydrolysis of organic substrates, being a major osteoblastic 
marker [142]. HA is known to influence osteoblastic cells differentiation and for 
creating a more biomimetic environment for these cells, since HA is the inorganic 
component of bone tissue [136]. HA particle size has been described to influence 
osteoblastic cell behaviour. The particle size of the HA particles used in the present 
work was ~20 nm, which has been shown to allow for an enhanced osteoblastic 
response when incorporated in films, compared to that seen in films containing micro-
HA particles [143]. It has been reported that films, granules or composite materials 
manufactured with HA nanoparticles exhibit a surface with improved osteoblastic 
activity and new bone formation, suggesting a clear advantage in bone tissue 
applications, compared to conventional HA microstructured materials [144]. In the 
present work, the agglomeration of the nanoparticles led to the formation of bigger 
sized particles, still in the nanorange in the 2% HA PEI composite, but as 
submicron/micron particles’ clusters in the 5% HA PEI coating. The agglomeration of 
the nonaparticles also increased the coating roughness especially with 5% HA, which is 
reported to enhance cell adhesion and proliferation [145]. 
AZ31 Mg alloy coated samples showed a better performance compared to uncoated 
samples. The polymeric coatings controlled corrosion rate and increased osteoblastic 
cytocompatibility. These results are in accordance to literature reports [53,84,85,87,89]. 
The polymeric coatings have shown to delay degradation in physiological environment 
[10,11], increase biocompatibility [86,88] and increase formation of bone of coated 
alloys after implantation in a rabbit model [88]. 
The results described in this chapter have shown that modification of the magnesium 
alloys surface can improve the performance of the alloys. Anodisation showed to 
enhance the cells attachment to the surface and further growth. Although the promising 
results, the performance of these anodised materials was still lower than the one 
observed in control cultures. The polymeric PEI- and PCL-based coatings showed a 
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better biocompatibility, allowing cell adhesion and proliferation. Furthermore, the 
results demonstrated that the best cellular response was achieved with the coatings 
containing nanoparticles of HA.  
In conclusion, the coatings proposed in this work increased the biocompatibility of 
AZ31 alloy, by tailoring the corrosion rate of the alloy. The coated magnesium alloys 
appear as a promising strategy to obtain biologically safe and active implant materials. 
 
 
  
 
 
 
 
 
Chapter 5 
Indirect cytocompatibility assays 
Cell behaviour in the presence of extracts from the Mg-based 
substrates 
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An important factor when testing degradable materials, as the Mg-based materials, is 
the type of cytocompatibility tests performed. Two well-established in vitro tests used in 
these materials are the direct and indirect assays. The direct assays are based in seeding 
cells on the surface of Mg alloys, as those accomplished in the previous chapter. The 
indirect assays allow the evaluation of Mg alloy compatibility by analysing the effect of 
corrosion products released to culture medium, therefore avoiding the effect from the 
highly dynamic surface of the alloy [7]. 
In the previous chapter, a series of Mg-based materials and coatings were tested for 
the direct cytocompatibility of substrates with increasing resistance to corrosion in 
physiologic environment. The results showed that both, anodisation and polymeric 
coatings, which decreased the degradation rate of Mg alloys, such as AZ31, resulted in 
increased biological performance towards osteoblastic cells. 
In this chapter, a series of extracts from Mg-based substrates were tested in cells 
relevant for bone tissue regeneration: osteoblastic-induced human mesenchymal stem 
cells (hMSC), osteoclastogenic-induced human precursor osteoclastic cells (PMBC) and 
human endothelial cells (HUVECs). The assayed materials used to produce the extracts 
were AZ31, anodised AZ31 and anodised AZ31 coated with PEI+DETA+2%HA. The 
last material is a combination of anodisation and the coating with the best performance 
described in the previous chapter. 
Cultures of hMSC, PBMC and HUVECs were performed in the presence of a 
concentration range of the extracts for a period of 21 days (osteoblastic cell cultures and 
osteoclastic cell cultures) and 7 days (endothelial cell cultures) and were characterized 
for the respective cell phenotype behaviour. The concentration range of the tested 
extracts was the same for the various cell types: 50%, 20%, 10%, 5% and 2% of the 
undiluted extract, prepared as described in the section “Materials and Methods”. 
Another important thing is to discern the effect of the Mg ion in the cell response 
observed in the indirect assays. Thus, in the second part of this chapter, a series of Mg 
concentrations where tested in the same cell types and the cell behaviour was analysed 
for the respective cell phenotype. 
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5.1 Effects of the extracts from Mg-based substrates in the osteoblastic, 
osteoclastic and endothelial cell response 
 
5.1.1 Osteoblastic behaviour of human mesenchymal stem cells exposed to the 
extracts from the Mg-based substrates 
 
hMSC were used has a model to evaluate the effect of extracts from Mg-based 
materials on osteoblastic cells. hMSC were cultured for 21 days in the presence of the 
extracts from the Mg-based substrates, using the experimental protocol described in the 
Chapter 3. The cells were also cultured in the presence of dexamethasone and β-
glycerophosphate to induce the osteogenic differentiation of hMSC. 
The extracts used in this work were obtained from three Mg-based materials: AZ31, 
anodised AZ31 and anodised AZ31 coated with PEI+DETA+2%HA. A set of 5 extract 
concentrations (50%, 20%, 10%, 5%, 2%) was analysed for the ability to interfere with 
viability, proliferation and functional activity of hMSC for 21 days. 
Figure 18 shows the effects of the materials’ extracts in cell viability/proliferation 
and DNA content during the 21-day culture time. In control cultures, there was an 
increase in viability/proliferation between days 7 and 14, and at a less extend at day 21. 
This increase was accompanied with an increase in DNA content.  
hMSC cultured in the presence of extracts from AZ31 alloy presented significant 
differences compared to control cultures. At day 7, there was a tendency for an increase 
in the cell viability/proliferation in the presence of the extracts. At day 14, with the 
higher extract concentrations, 50% and 20%, the viability/proliferation (Figure 18.a) 
and DNA content (Figure 18.d) were significantly lower. At concentrations of 10% and 
5%, the viability/proliferation increased when compared to control cultures, attaining 
statistical significance at day 14. At day 21, the exposure to the extracts decreased 
viability/proliferation of all concentration, except at 2%. Regarding DNA content, at 
day 21 the culture exposed to extracts from 20% to 2% maintained a similar result to 
control cultures. 
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Figure 18. Cell viability/proliferation (a, b and c; MTT assay) and DNA content (d, e 
and f) of hMSC exposed to the extracts from the Mg-based substrates, at days 7, 14 and 
21. *Significantly different from control (absence of extract). 
 
hMSC cultures exposed to the extracts from anodised AZ31 presented similar results 
to those observed with AZ31 extracts. At day 7, cultures exposed to the extracts 
presented an increased viability/proliferation. At day 14, the viability/proliferation of 
cultures exposed to concentrations of 50% and 20% showed a decrease in 
viability/proliferation, accompanied by a decrease in DNA content. The remaining 
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concentrations presented similar results to those observed in control cultures. By day 
21, the majority of the cultures exposed to the different extract concentrations had 
decreased viability/proliferation, although similar DNA content compared to control. 
hMSC cultured in the presence of extracts from anodised AZ31 coated with 
PEI+DETA+2%HA were less affected. In this case, there were no significant 
differences between control cultures and cultures exposed to the extracts. The cells were 
able to proliferate in a rate similar to control cultures. 
 
 
 
Figure 19. Alkaline phosphatase activity of hMSC exposed to the extracts from the Mg-
based substrates, at 7, 14 and 21 days. * Significantly different from control cultures 
(absence of the extracts). 
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An important marker for hMSC is ALP activity, a measure for functional activity of 
osteoblastic cells. Figure 19 summarizes the results for ALP activity. In control cultures, 
ALP activity increased between day 7 and day 21. At day 7, ALP activity was similar in 
control and exposed cultures. The cultures exposed to high concentrations of extract 
from AZ31 alloy showed decreased ALP activity at day 14 (50% extract) and day 21 
(50 and 20% extracts), which was in accordance to the viability results. However, 10 
and 5% extracts increased ALP activity at day 14. By day 21, ALP activity was similar 
to control with the 10 to 2% extracts. A similar behaviour was observed in hMSC 
exposed to the extracts from anodised AZ31. At day 14, ALP activity increased with 10 
and 5% extracts. In the same way, the 50% extract caused a decreased activity. The 
extracts from anodised AZ31 coated with PEI+DETA+2%HA had no effects in ALP 
activity compared to control cultures. 
The results from viability/proliferation, DNA content and ALP activity showed that 
the extracts had clear effects, especially for AZ31 and anodised AZ31. High extract 
concentrations decreased cell viability and ALP activity. However, increased 
viability/proliferation and ALP activity was observed in the presence of 10% and 5% 
extracts, at day 14. Taking this into account, the effect of the 10% extract was further 
analysed to better characterize the osteogenic response. 
Figure 20 represents the gene expression of osteoblast-related proteins in control 
cultures and cultures exposed to the extracts, at 10% concentration, measured at day 14. 
All cultures expressed the osteoblast-related genes: ALP, Runx-2, Col-1, BMP-2, OPG 
and osteocalcin. Cell cultures exposed to extracts showed an increase in the expression 
of ALP, Runx-2 and OPG. This effect was specially observed in the cell cultures 
exposed to the extract from anodised AZ31.  
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Figure 20. RT-PCR gene expression of hMSC exposed to the extracts from the Mg-
based substrates, at a concentration of 10%, at days 14. A) RT-PCR products were 
subjected to a densitometric analysis and were normalized to the corresponding 
GAPDH value. *Significantly different from control (absence of the extract). B) 
Representative gel band images: a) Control, b) AZ31, c) Anodised AZ31 and d) 
Anodised AZ31, coated with PEI+DETA+2%HA. 
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Figure 21 shows representative images of histochemical staining for ALP and 
collagen, at days 14 and 21. In all cultures, ALP staining increased from day 14 to day 
21. Cultures presented a characteristic pattern of cell growth, namely exhibiting areas of 
higher cell density randomly distributed on the culture surface. Cell cultures in contact 
with the 10% AZ31 and anodised AZ31 extract presented an increase in ALP, showing 
a darker coloration at day 21 compared to control cultures.  
 
 
 
Figure 21. Representative images of hMSC cultures exposed to the extracts from the 
Mg-based substrates (10% dilution), and stained for ALP (a, b) and collagen (c, d), at 
days 14 (a, c) and 21 (b, d). bar: 200μm. 
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Figure 22. ALP activity of hMSC cultured in the presence of signalling pathways 
inhibitors, at day 14. a) Effect of signalling pathways inhibitors in control cultures, b)% 
of variation of ALP activity in cultures performed in the presence of 10% extracts. 
U0126: MEK signalling pathway inhibitor; PDTC: NF-kB signalling pathway inhibitor; 
SP600125: JNK signalling pathway inhibitor; SB202190: p38 MAPK signalling 
pathway. ** significantly different from the cultures performed in the absence of 
inhibitor. * significantly different from the control cultures. 
 
Figure 22 shows the results for ALP activity of the cultures exposed to the extracts 
and performed in the presence of inhibitors of several signalling pathways, at day 14.In 
control cultures, the addition of the inhibitors (Figure 22.a) caused a decreased in ALP 
activity of hMSC. The NF-KB (PDTC) and JNK (SP600125) signalling pathways 
showed a more pronounced effect in these cultures, with significant inhibition of ALP 
activity after the inhibitors were added.  
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Figure 22.b presents the effects of the Mg-based extracts (10%) plus the signalling 
pathways inhibitors. In the cultures exposed to AZ31 extract, it was found a significant 
decrease in ALP activity in all cultures exposed to the inhibitors when compared to the 
culture performed with no inhibitors. Comparing to control cultures exposed to the same 
inhibitors, it was observed a significant decrease in ALP activity for MEK signal 
pathway. Both, NF-KB and JNK signal pathways were down-regulated in the presence 
of this extract, i.e. increased ALP activity. In cultures exposed to anodized AZ31 extract 
it was observed a decrease in ALP activity in the cultures exposed to the signal 
pathways inhibitors. Compared to control cultures, the inhibitor for MEK signal 
pathway significantly decreased ALP activity. It was observed with the AZ31 extract, 
NF-KB and JNK signal pathways were also down-regulated in the presence of this 
extract. With the exception of MEK signal pathway, all inhibitors significantly 
decreased ALP activity in the culture exposed to the extract from coated AZ31 with PEI 
compared to the culture performed with no inhibitors. Compared to control cultures, 
NF-KB and JNK were also down-regulated as observed in the other extracts tested. The 
p38 MAPK was found to have a similar effect in all tested extracts, with no significant 
differences compared to control. 
In conclusion, the extracts from AZ31 alloy and anodized AZ31 alloy were found to 
be toxic at high concentrations, such as 50% and 20%. At lower concentrations, these 
extracts stimulated viability/proliferation, ALP activity and expression of some 
osteoblastic genes on hMSC cultures. The extract from anodized AZ31 alloy coated 
with PEI+DETA+2%HA was nontoxic in the tested concentration range, and hMCS 
presented a behavior similar to control. 
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5.1.2 Osteoclastic behaviour of peripheral blood mononuclear cells exposed to 
the extracts from the Mg-based substrates 
 
Osteoclastic cell cultures were established by culturing PBMC in the presence of M-
CSF and RANKL for 21 days, using the methodology described in Chapter 3. 
Osteoclastic behaviour was evaluated in the presence of the extracts (50% to 2%) from 
the three Mg-based materials, at days 7, 14 and 21.  
Figure 23 shows the results for DNA content and caspase-3 activity of the 
osteoclastic cultures. In control cultures, DNA content decreased between day 7 and day 
21. In the presence of the extracts from the three Mg-based alloys, cell cultures had a 
similar pattern of behaviour, although showing significant differences compared to 
control cultures.  
AZ31 extracts, at high concentrations (50 to 10%), caused an increase in the DNA 
content at day 7, followed by a significant decrease at days 14 and 21 (50 and 20%). 
Extracts from AZ31 anodized alloy increased DNA content at days 7 and 14 (50 to 5%) 
and at day 21 (10 and 5%); however the 50 and 20% extracts inhibited DNA content at 
day 21. Extracts from the coated alloy did not affect DNA content, compared to control. 
Caspase-3 activity is used to measure the level of apoptosis in cell cultures, as an 
increase in the activity of this enzyme in indicative of high apoptosis rate. Figure 23 (d, 
e and f) shows the effect of Mg-based extracts, in percentage relative to control. At day 
7, the presence of extracts from AZ31 decrease the percentage of apoptosis compared to 
control. However, at day 14 and 21, cells exposed to higher concentrations of the extract 
showed an increase in the amount of apoptosis compared to control. Cell cultures 
exposed to anodised extracts showed a similar result to control at day 7. At day 14 and 
21, a decrease in apoptosis was observed for lower concentrations (10% and 5%). Also, 
it was observed an increase of apoptosis in cell cultures exposed to 50% extract, at day 
21. Cell cultures exposed to extracts from coated AZ31 showed an apoptosis rate 
similar to control. 
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Figure 23. DNA content (a, b and c) and percentage of caspase-3 activity (d, e and f) of 
human osteoclastic cell cultures in the presence of the extracts from the Mg-coated 
materials.* Significantly different from control (absence of the extracts). 
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Figure 24 shows the effects of Mg-based extracts in TRAP activity and number of 
TRAP positive multinucleated cells. In control cultures, TRAP activity increased 
throughout the culture period, attaining its higher value by day 21. Extracts from AZ31 
did not affect TRAP activity at day 7. However, with the 50% dilution, a significant 
decrease in TRAP activity was observed at days 14 and 21. Dilutions of 10 and 5% 
increased the enzyme activity at day 14. Extracts from the anodized alloy, at 10% 
dilution, increased TRAP activity at days 7 and 14, whereas with the 50 and 20% 
dilutions the enzyme activity was significantly decreased at days 14 and 21. Extracts 
from the polymeric coated alloy showed results similar to control cultures. 
Histochemical TRAP staining of osteoclastic cultures was performed, and the number 
of TRAP positive multinucleated cells is depicted in Figure 24.d, e and f. In control 
cultures, the number of these cells appeared to increase from day 7 to day 14, and was 
similar between days 14 and 21 (Figure 24). At high concentration of extract, from 
AZ31, the number of cells was low for all culture periods. At lower concentrations the 
amount of TRAP positive multinucleated cells was similar to control cultures. The 
extracts from anodised AZ31 had similar results, with a low amount of cells when 
higher concentrations of extracts were added to the culture. Also, concentrations around 
10% to 5% had a stimulatory effect on the number of multinucleated cells. The extracts 
from polymeric coated alloy showed results similar to control cultures. 
The previous results showed that the extracts at a concentration of 10% induced 
significant alterations in the cell behaviour. Therefore, cell response was further 
analysed for gene expression and signalling pathways, at day 14.  
 
 
81 
 
 
Figure 24. TRAP activity (a, b and c) and number of TRAP positive multinucleated 
cells (d, e and f) on osteoclastic cell cultures performed in the presence of the extracts 
from the Mg-based materials. * Significantly different from control cultures. 
 
 
Gene expression of important proteins for osteoclastogenesis is shown in Figure 25. 
Extracts from AZ31 and anodised AZ31 were able to increase the expression of TRAP 
and Ca2. The extracts from AZ31 coated with PEI showed no significant differences 
from control cultures.  
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Figure 25. RT-PCR gene expression of osteoclastic cells exposed to the extracts from 
the Mg-based materials, at day 14. A) RT-PCR products were subjected to a 
densitometric analysis and were normalized to the corresponding GAPDH value. 
*Significantly different from control (absence of the extracts). B) Representative gel 
band images: a) control, b) AZ31, c) anodised AZ31, d) Anodised AZ31, coated with 
PEI+DETA+2%HA. 
 
 
An important issue is the effect of the extracts on signalling pathways involved on 
osteoclastogenesis. The pathways analysed in hMCS were also addressed in osteoclastic 
cell cultures. The cultures exposed to 10% of the extracts were performed in the 
presence of specific inhibitors, and characterized for TRAP activity at day 14 (Figure 
26). In control cultures, the addition of the inhibitors affected TRAP activity (Figure 
26.a). The effect was more pronounced in control cultures exposed to NF-KB, followed 
by MEK and p38 MAPK signal pathway inhibitors. Figure 26.b depicts the combined 
effects of extract at 10% and the inhibitors. With the AZ31 extracts, the signal pathways 
inhibitors were able to decrease TRAP activity of the cultures. Compared to control, 
MEK and NF-KB were down-regulated, i.e. the effect in TRAP activity was less 
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pronounced. In the presence of the anodised AZ31 extracts, it was also observed a 
decrease in TRAP activity after the inhibitors were added, with the exception of JNK 
signalling pathway. Compared to control, the effect of the inhibitors was less 
pronounced. With the extracts from coated AZ31, results were similar to those observed 
in the cultures with no inhibitor, except for NF-KB signal pathway. It was also observed 
a down-regulation of all the signal pathways compared to control, i.e. TRAP activity 
was increased. 
 
 
Figure 26. TRAP activity of osteoclastic cells exposed to the extracts from the Mg-
based materials, performed in the presence of specific signalling pathways inhibitors a) 
Effect of signalling pathways inhibitors in control cultures, b)% of variation of TRAP 
activity in cultures performed in the presence of 10% extracts. U0126: MEK signalling 
pathway inhibitor; PDTC: NF-kB signalling pathway inhibitor; SP600125: JNK 
signalling pathway inhibitor; SB202190: p38 MAPK signalling pathway. ** 
significantly different from the cultures performed in the absence of inhibitor. * 
significantly different from the control cultures. 
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In conclusion, the extracts from AZ31 and anodised AZ31 showed a high toxicity at 
higher concentrations (50% to 20%), with a decrease in DNA content and increase of 
apoptosis. Lower concentrations caused a stimulatory effect , which was observed by 
the increase in TRAP activity and the expression of ALP and Ca2 genes, at 10%. The 
extracts from polymer coated AZ31 did not affect cell behaviour, as the results were 
similar to those observed in control cultures. 
 
 
 
5.1.3 Behaviour of human endothelial cells exposed to the extracts from the Mg-
based substrates 
 
HUVECs were used as a model to evaluate the endothelial cell behaviour in the 
presence of the extracts from Mg-based materials. HUVECs were cultured for 7 days in 
the presence of the extracts from AZ31 alloy, anodised AZ31 and anodised AZ31 
coated with PEI+DETA+2%HA, using the protocol described in Chapter 3. 
Firstly, HUVECs were cultured in the presence of different concentrations of the 
extracts, and evaluated at days 1, 4 and 7. The effect on viability/proliferation is shown 
in figure 10. Cell proliferation increased throughout the culture time in control cultures 
and cultures exposed to the extracts. 
The extracts from AZ31, at the highest extract concentration, 50%, decreased 
significantly the viability/proliferation, whereas the 20% extract had a stimulatory effect 
at days 1 and 4, and the presence of the 10 to 2% extracts did not affect the cell 
response (Figure 27). The 50% extract from anodised AZ31 alloy also presented a 
tendency to be toxic, with lower values at days 1 and 4, although without attaining 
statistical significance. The cultures exposed to the 20% extract presented increased 
viability/proliferation at day 4. Cultures exposed to the remaining extract concentrations 
(10%, 5% and 2%) presented a viability/proliferation similar to that on control cultures. 
HUVECs cultured in the presence of the extracts from anodised AZ31 coated with 
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PEI+DETA+2%HA had a response similar to that observed with the anodised AZ31 
alloy, Figure 27. 
 
 
 
Figure 27. Cell viability/proliferation of HUVECs cultured in the presence of the 
extracts from the Mg-based materials, for 7 days. * Significantly different from control 
(absence of the extracts). 
 
 
From the results obtained in the cell viability/proliferation, it was observed that the 
20% and 10% (at a smaller level) extract concentrations had a stimulatory effect. This 
was specially seen for the extracts from AZ31 and anodised AZ31. So, cell response 
was further analysed for DNA content, caspase activity (apoptosis) and nitric oxide 
synthesis, at days 4 and 7. 
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Figure 28. DNA content and Caspase-3 activity and NO concentration of HUVECs 
cultured in the presence of the extracts from Mg-based materials, 20% and 10%, at days 
4 and 7. * Significantly different from control cultures (absence of the extracts). 
 
DNA content of all cultures increased from day 4 to day 7, evidencing a growing 
cell population (Figure 28). Comparing to control cultures, there was a tendency for the 
extracts from anodised AZ31 and anodised AZ31 coated with PEI+DETA+2%HA to 
increase DNA content, although without attaining statistical significance. 
In all cultures, there was a small increase in caspase-3 activity from day 4 to day 7 
(Figure 28). At day 7, the cell layer was close to confluence which increases the amount 
of cell death by apoptosis. However, this behaviour was similar in control cultures and 
in the cultures exposed to the extracts from the three materials. 
NO synthesis is an important marker of endothelial cells. The synthesis of NO, 
normalized to the protein content, was similar at days 4 and 7 (Figure 28). Additionally, 
no differences were found between control cultures and those exposed to the extracts.  
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Figure 29. RT-PCR gene expression of HUVECs cultured in the presence of the extracts 
from the Mg-based alloys. a) RT-PCR products were subjected to a densitometric 
analysis and were normalized to the corresponding GAPDH value. * Significantly 
different from control (absence of the extracts. b) Representative gel band images. 
 
 
Expression of the endothelial genes VE-Cadherin, CD31 and VWF was analysed at 
day 4 (Figure 29). VE-Cadherin presented an increased expression in the cells exposed 
to the extracts from the Mg-based alloys, except for the 20% AZ31 extract. The same 
tendency was observed for the expression of CD31, although statistical significance was 
only observed with the extracts from anodised AZ31 coated with PEI+DETA+2%HA. 
VWF expression was similar in all cultures. 
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The in vitro ability to organize the cell layer in a network of cord-like formations 
under certain conditions, i.e. upon contact with an extracellular matrix, is an important 
feature of endothelial cells, suggesting its functional performance in undergoing 
angiogenesis. For this assay, HUVECs were cultured for 4 days, in control conditions 
and in the presence of the extracts. The cell layer attained a confluence of about 70% in 
all cultures. At this stage, Matrigel (an extracellular matrix) was added to the cultures, 
and the organization of the cell layer was documented after 24h (details of the 
methodology were described in Chapter 3). Representative images are shown in Figure 
30. All cultures, control and exposed to the extracts, organized the cell layer in a 
network of tube-like structures, and no differences were noted between the control 
cultures and those exposed to the extracts.  
 
 
 
Figure 30. The Matrigel assay: representative images of HUVECs cultured in control 
conditions and in the presence of the extracts from the Mg-based materials (20 and 
10%), showing the organization of the cell layer in a network of cord-like structures 
upon the addition of Matrigel. Bar: 200 μm. 
 
 
The effect of the extracts from the Mg-based substrates in angiogenesis was also 
evaluated in in vivo conditions, by performing the CAM assay (Chapter 3). In this work, 
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a piece of filter paper, impregnated with the extracts, was placed in the surface of the 
chicken chorioallantoic membrane. The extracts were tested undiluted. After three days, 
the number of blood vessels formed around the paper filter was quantified. 
Angiogenesis was observed in all conditions, as observed in Figure 31. In control 
conditions, a slightly higher number of blood vessels was counted, compared to that 
found with the extracts. However, this difference did not attain statistical significance.   
 
 
 
Figure 31. The CAM assay: effect of the extracts from the Mg-based alloys in the 
angiogenic response. a) representative images of the angiogenic response surrounding 
the filter samples impregnated with the extracts; b) number of blood vessels counted in 
the presence of the extracts.  
 
The results presented in this section showed that the extracts from the three Mg-
based alloys, at concentrations of 20 and 10% increased the cell viability/proliferation 
of HUVECs. Also, an increase in the expression of VE-Cadherin and CD31 was 
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observed with the same extract concentrations. Additionally, the in vitro and the in vivo 
angiogenesis assays showed similar behaviour in control conditions and in the presence 
of the extracts, suggesting a reduced or absence of toxicity of the extracts.  
 
 
 
5.2 Effects of Magnesium ion on the osteoblastic, osteoclastic and 
endothelial cell response 
 
The results regarding the behaviour of osteoblastic, osteoclastic and endothelial cell 
cultures in the presence of the extracts from the Mg-based alloys with different surface 
treatments showed interesting dose-dependent effects. Overall, higher extract 
concentrations caused cytotoxic effects, but lower concentrations had a stimulatory 
effect. To understand the contribution of the Mg ion in the observed results, the three 
types of cell cultures were performed in the presence of a concentration range of Mg 
(1mM to 100mM), in the form of MgCl2, and the cell response was characterized for 
viability/proliferation and specific phenotype markers. 
 
Figure 32 shows the results of hMCS cultured in the presence of a set of Mg 
concentrations, from 1mM to 100mM. Overall, levels similar and higher than 20mM 
Mg caused dose-dependent inhibitory effects in the viability/proliferation (Figure 32.a) 
DNA content (Figure 32.b) and ALP activity (Figure 32c). However, at a concentration 
of 1 mM, Mg increased ALP activity by ~30%, Figure 32c. 
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Figure 32. Osteoblastic behaviour of hMSC exposed to Mg, 1 to 100 mM, at days 7, 14 
and 21. a) Viability/proliferation (MTT assay), b) DNA content and c) ALP activity. * 
Significantly different from control cultures. 
 
 
Cultures of hMSC, exposed to 1 mM and 10mM Mg, were performed in the 
presence of several signalling pathways inhibitors and characterized for ALP activity 
(Figure 33). In control cultures, all inhibitors decreased ALP activity, as previously 
observed. Cultures exposed to 1 and 10mM of Mg showed a decrease in ALP activity 
when exposed to the inhibitors (Figure 33.b). When compared to control cultures, 
cultures exposed to 1 and 10mM of Mg showed an up-regulation of MEK and NF-KB 
signalling pathways, i.e. the decrease of ALP activity was more pronounced. Both, JNK 
and p38 MAPK signal pathways showed similar results to those observed in control. 
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Figure 33. ALP activity of hMSC exposed to Mg, 1mM and 10 mM, in the presence of 
signalling pathway inhibitors, at day 14. a) Effect of signalling pathways inhibitors in 
control cultures, b) % of variation of ALP activity in cultures performed in the presence 
of 1mM and 10mM of Mg. U0126: MEK signalling pathway inhibitor; PDTC: NF-kB 
signalling pathway inhibitor; SP600125: JNK signalling pathway inhibitor; SB202190: 
p38 MAPK signalling pathway. ** significantly different from the cultures performed 
in the absence of inhibitor. * significantly different from the control cultures. 
 
 
The influence of Mg ion was also analysed in osteoclastic cell cultures. Figure 34 
presents the results for DNA content, TRAP activity and Caspase-3 activity (apoptosis). 
Mg ion increased DNA content in the range 10 to 50 mM. Regarding caspase-3 activity, 
decreased values were observed with 10 to 50 mM, and increased values with 100 mM. 
Mg ion also increased TRAP activity at 10 to 20 mM and had an inhibitory effect at 100 
mM (day 14) and 50 and 100 mM (days 14 and 21).  
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Figure 34. Osteoclastic cell behaviour of cultures exposed to Mg, 1 to 100 mM, at days 
7, 14 and 21. a) DNA content, b) TRAP activity and c) Caspase-3 activity. * 
Significantly different from control cultures. 
 
Mg concentrations of 10 and 20 mM showed a stimulatory effect in osteoclastic cell 
cultures, so they were further analysed for the effects in several signalling pathways 
involved in osteoclastogenesis. Figure 35 presents the results for TRAP activity of the 
cultures performed in the presence of specific signalling pathways inhibitors. All 
inhibitors decreased TRAP activity in control cultures (Figure 35.a) Cell cultures 
exposed to 10 and 20 mM showed a decrease in TRAP activity compared to the same 
conditions without the inhibitors. MEK, NF-KB and p38 MAPK signal pathways 
showed a down-regulation after the addition of 10 and 20 mM of Mg. The opposite 
effect was observed for the JNK signal pathway, i.e. it was observed a decreased in 
TRAP activity compared to the results in control cultures. 
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Figure 35. TRAP activity of osteoclastic cells exposed to Mg, 10 mM and 20 mM, in 
the presence of signalling pathway inhibitors, at day 14. a) Effect of signalling pathways 
inhibitors in control cultures, b) % of variation of TRAP activity in cultures performed 
in the presence of 10 mM and 20 mM of Mg. U0126: MEK signalling pathway 
inhibitor; PDTC: NF-kB signalling pathway inhibitor; SP600125: JNK signalling 
pathway inhibitor; SB202190: p38 MAPK signalling pathway. ** significantly different 
from the cultures performed in the absence of inhibitor. * significantly different from 
the control cultures. 
 
 
The effect of Mg ion on the behaviour of endothelial cell cultures was also analysed, 
and the results are summarised in Figure 36. Cell cultures exposed to high 
concentrations of Mg ions, 20 to 100 mM, showed a decrease in viability/proliferation 
accompanied by an increase in caspase-3 activity (apoptosis). Cell cultures exposed to 
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Mg concentrations between 1 and 10 mM showed results similar to control cultures. 
The presence of Mg ion did not affect the synthesis of NO by endothelial cells. 
 
 
Figure 36. Endothelial behaviour of HUVECs cultures exposed to Mg concentrations, 1 
to 100 mM, at days 1, 4 and 7 . a) Viability/proliferation (MTT assay), b) DNA content, 
c) capase-3 activity and d) NO concentration. * Significantly different from control 
cultures. 
 
 
Figure 37 shows the results observed in the Matrigel assay for endothelial cell 
cultures exposed to Mg ion, 1, 10 and 20 mM. Control cultures were able to organize 
the cell layer in a network of tube-like formations, upon the contact with Matrigel. Mg 
ion caused a dose-dependent inhibitory effect, which began to be apparent with 1 mM 
and was significant with 20 mM.  
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Figure 37. The Matrigel assay: representative images of HUVECs cultured in control 
conditions and in the presence of Mg ion, showing the organization of the cell layer in a 
network of cord-like structures, upon the addition of Matrigel . Control cultures (a) and 
cultures exposed to 1 mM (b), 10mM (c) and 20 mM (d) of Mg. bar: 200μm. 
 
Mg ion showed dose-dependent effects in osteoblastic, osteoclastic and endothelial 
cell cultures, although with noticeable differences among the three cell populations. At 
high concentrations, 50 and 100 mM, Mg ion caused a common inhibitory effect in the 
cell response. hMSC and endothelial cells were not significantly affected by lower 
concentrations of Mg ion (1 and 10 mM). However, osteoclastic cell cultures showed an 
increase in the DNA content and TRAP activity at concentrations of 10 and 20 mM.  
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5.3 Discussion 
 
The results obtained in the previous chapter showed a better biocompatible 
performance in coated alloys, especially for polymeric coatings such as PEI and PCL. It 
is difficult to compare with other reports since the composition and methods, used to 
create the various coating, vary greatly. Also, it has being described that the effects can 
show a discrepancy depending on the type of cytocompatibility tests [100]. Two types 
of test can be used to analyse citocompatibility of degradable materials, direct test such 
as performed in the previous chapter of this work and indirect test. The results of the 
direct assays are influenced by the corrosion of the alloy itself, hence it has been 
difficult to isolate the effect of increased corrosion rate and the toxicity of the Mg or 
other alloying components [146]. In indirect tests, cells are cultured in the presence of 
different concentrations of extracts, avoiding the effects from the dynamic surface 
present in Mg alloys in a physiologic environment [7].  
In this work, the indirect cytocompatibility of magnesium alloy AZ31, anodised 
AZ31 and anodised AZ31 coated with PEI +DETA+ 2% HA was evaluated in three cell 
types: human mesenchymal stem cells (osteogenic induced), human precursor 
osteoclastic cells (osteoclastogenic induced) and human endothelial cells. Cell cultures 
were evaluated for viability/proliferation and also specific characteristics of the cells. 
The extracts were prepared by incubation of the Mg alloys in culture medium for 24h, 
and tested in the cells at different concentrations (50, 20, 10, 5 and 2%). 
Osteogenic-induced hMSC were used to evaluate the effect of Mg-based extract and 
Mg ion in osteoblastic cells. It was observed a high cytotoxicity of hMSC exposed to 
high levels of extracts from AZ31 and anodised AZ31. Also, it was observed an 
opposite effect when cells were exposed to 10% extracts. At this concentration, hMSC 
increased viability/proliferation, functional activity and gene expression of ALP, Runx-
2 and OPG. The results indicate an increase in differentiation of hMSC to osteogenic 
lineage, corresponding to an increase in ALP activity [125], and expression of important 
osteoblastic-related genes such as ALP, Runx-2 and OPG [147]. A similar result has 
been described previously, i.e. an increase in proliferation and differentiation of hMSC, 
including increased expression of BMP-2, with extracts from Mg, Mg-1Y and Mg-5Al 
alloys [110]. Also, using MG-63 cells, Pichler et al. (2014) showed an increase in gene 
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expression of ALP and osteocalcin in cultures incubated with extracts from Mg-based 
materials [111]. 
Osteoclastic-induce PMBC were used to analyse the effect of Mg- based extracts 
and Mg ion concentration in osteoclastic lineage. As previously observed in hMSC, 
high concentrations of extracts from AZ31 and anodised AZ31 (50 and 20%) inhibited 
the functional activity of these cells and decreased the number of cells. At 
concentrations 10% a stimulatory effect was observed with the increase in functional 
activity (TRAP) and gene expression of Ca2 and TRAP. Such features are an indication 
of the increase in differentiation of PMBC cells towards a osteoclastic lineage [126].  
The exposure of these two cell types to the extracts also influenced different cellular 
signalling pathways important in osteoblastogenesis and osteoclastogenesis. Both, 
AZ31 and anodised AZ31 induced an up-regulation of MEK signal pathway in 
osteoblasts, and a down-regulation of NF-KB and JNK. In osteoclastic cells, it was 
observed a down-regulation of all signalling pathways, with the exception of JNK. 
It has been described a better performance of Mg alloys when an indirect assay was 
used, as observed in this work. An Mg-Ca alloy showed high cytotoxicity when MG-63 
cells were cultured directly on the biomaterial, but in the indirect testing, the same 
material showed promising results [117]. Another work performed by Park et al. (2012) 
have described similar effects, with no deleterious effects of the conditioned medium, 
from MG-35Zn-3Ca alloys, in cell cultures [100]. Zhao et al. (2014) compared the 
results of both cytocompatibility studies obtaining similar results [115].  
In the present work, a similar result was observed in AZ31 and anodised sample 
extracts. Anodisation is reported to increase corrosion resistance of Mg alloys, with 
different degrees of results [119]. In a study using MC3T3 cells, cultured in the 
presence of extracts from AZ31, AZ91 and ZK60A and anodised samples, it was 
reported an alteration in viability depending on the base alloy. ZK60A showed a 
decreased viability in both samples, base and anodised. AZ31 and AZ91 showed an 
increase in viability of MC3T3 cell, especially the anodised samples [119]. 
The effects of the extracts in these cells can be influenced by various factors such as 
pH, osmolality of the culture medium, concentration of Mg ion and other alloying 
elements, etc. [43]. Both, osteoblasts and osteoclasts are influenced by pH in an 
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opposite manner. It has been described a steady increase in the activity of osteoblast 
cells in contact with a medium with a pH in the range 7.0 to 7.8 [148]. pH level of the 
culture medium has been found to influence osteoclast differentiation and function. 
Osteoclasts reabsorption activity was found to be activated by acidic levels in 
physiologic environment [149]. At a pH higher than 7.4, the reabsorption activity of the 
osteoclasts decreases. The inhibitory effect found at higher levels of extract (50% and 
20%) could be a direct result of pH increase of the medium. Besides pH alterations, it 
has been reported an increase in Mg2+ and a decrease in Ca2+ and PO43- in Mg materials 
incubated in Hank’s solution [139]. 
Mg ion concentration in the extracts is also an important factor contributing to the 
final results. The pure extract used in osteoblastic and osteoclastic cell cultures showed 
an increase in Mg ion compared to control cultures. In control cultures and polymeric-
coated sample de concentration of Mg was approximately 1 mM, while in the AZ31 
extract was 21 mM and in anodised AZ31was 14 mM. To evaluate the contribution this 
ion, a set of Mg concentration (1, 10, 20, 50, 100 mM) were analysed in this work. 
hMSC cells exposed to high concentration of MgCl2 (10 to 100 mM) showed a high 
toxicity, with a decrease in viability/proliferation and a decrease in ALP activity. These 
results are in accordance with the previous results observed in the extracts, since the 
concentration of Mg in the extracts at 50% would be close to 10 mM. A similar 
stimulation observed in extracts was also observed in the cells exposed to 1 mM of Mg, 
with an increase in viability/proliferation and ALP activity. It is possible that the effect 
observed in the extracts at 10% were related to the concentration of Mg ions present in 
the extracts. Yoshizawa et al. (2014) described a similar effect when testing bone 
marrow stromal cells in the presence of MgSO4 at concentrations between 1 to 10mM 
[150]. This observation suggested that the enhancement of bone tissue regeneration 
around Mg-based implants might be due to the presence of Mg ions. It has been 
described that materials supplemented with Mg2+ can lead to an improved osteoblastic 
cell adhesion, due to its influence in integrin receptors [116]. Integrins modulate cellular 
migration, proliferation, differentiation and apoptosis of different cell types such as 
osteoblasts. Mg2+ has an important role in the ion transport by pumps, carriers and 
channels, and possibly modulating signal transduction and the cytosolic concentration 
of electrolytes such as K+, Na+ and Ca2+ [39]. The depletion of Mg has also been 
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described to create impairment in bone growth, decrease osteoblast number and increase 
osteoclast number in young mice [2]. 
Osteoclastic cells exposed to Mg ion concentrations between 100 to 50 mM also 
show a reduction in functional activity. Also, the same cells exposed to 10 mM of Mg 
show an increase in functional activity. The results are in accordance to previously 
reports showing that a concentration of 25 mM of Mg could enhance osteoclasts 
function [151]. On the other side, the cells exposed to the extracts from Mg alloys were 
shown to be more affected by the concentrations of Mg ions, needing less amount of 
Mg to have a beneficial effect [151].  
The influence of Mg ion in the cellular signalling pathways important in 
osteoblastogenesis and osteoclastogenesis was also analysed. In osteoblastic cells, it 
was observed an up-regulation of MEK signal pathway, which is in accordance to the 
results observed in the Mg-based extracts. MEK signal pathway appears to have an 
important role in the effect of Mg extracts and Mg ion in osteoblastic cultures. The 
inhibition of this pathway, by U0126, is known to inhibit the ECM-dependent induction 
of the osteocalcin and BMP action in osteoblasts [152] and, as observed in this work, 
decreases the activity of ALP. MEK signal pathway (MEK/ERK) is also one of the 
primary transducers of integrin signals to the cell nucleus [152]. Mg ion is also known 
to be a co-regulator and activator of integrins [4], which could explain the importance of 
the MEK signal pathway in the effects observed this work. 
In osteoclastic cell cultures, a down-regulation of all signal pathways was observed, 
with the exception of JNK. These results are also in accordance to observe in the 
extracts tested. JNK signal pathway is important in osteoclastogenesis [153] and has 
been showed to have a role in the regulation of apoptosis of osteoclasts [154]. It is 
possible that the influence of Mg ion in osteoclastogenesis is regulated by other signal 
pathways besides the ones studied in this work. Osteoclastogenesis is a complex process 
regulated by various proteins, such as RANKL, and signal pathways [153]. 
Endothelial cells were also analysed for the citocompatibility in the presence of Mg 
extracts and Mg ions. It was observed a lower influence of Mg extracts from AZ31 and 
anodised AZ31 in these cells. Only at the highest concentration analysed, 50%, a 
deleterious effect of Mg extracts was observed. By measuring the concentrations of Mg 
ion in the extracts used in these cells it was found a lower concentration compared to 
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that observed in the previous medium (osteoblastic and osteoclastic cells). While in the 
control medium the concentration of Mg was the similar (1 mM), the concentration of 
pure extract from AZ31 was 17 mM and in the anodised sample was 14 mM. At a 
concentration of 20 to 10%, the extracts caused a stimulatory effect in cell 
viability/proliferation and increased the expression of ve-cadherin. In the other 
important characteristics, such as NO production, apoptosis and production of lumen-
like structure in the presence of an extracellular matrix there were no significant effects. 
Also, the results from the in vivo analyses, CAM assay, showed almost no effect from 
the concentrated extracts of AZ31 and anodised AZ31. Endothelial cells exposed to 
high level of Mg ion, between 20 to 100mM, showed a decrease in 
viability/proliferation especially at day 7. Also, in the presence of an extracellular 
matrix, the capability of producing a lumen-like structure was found to be impaired at 
concentrations higher than 20 mM. It has been reported that concentration around 10 
mM of extracellular Mg ion could stimulate the proliferation of endothelial cells, such 
as human coronary artery endothelial cells [155]. Also, Mg ion concentrations up to 10 
mM have been described to increase migration rate of endothelial cells, angiogenesis 
and cell adhesion [156,157].  
The results described for the extracts from AZ31 and anodised AZ31 indicated to be 
dependent on the concentration but also on the cell type. The same was found in the 
cultures incubated with different concentrations of Mg ion. Although the effect at high 
levels of extracts was similar for the different types of cells, the concentration that could 
be beneficial for the cells was different. 
The extracts produced from anodised AZ31 coated with PEI+DETA+2%HA were 
found to have no significant effect in all cell cultures used in this work. These results 
are in accordance with the results in the direct assay, in previous chapter. The coating 
with PEI has shown to enhance cells attachment and proliferation. Also it is reported 
that this coating increase the corrosion resistance of the Mg material [55], hence 
decreasing the amount of corrosion products being released to the culture medium. This 
is also evident in the concentration of Mg ion in the polymeric coating extract, which is 
similar to that observed in the control culture medium. 
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So, using the polymeric coating would increase cells attachment in a first period, but 
as the coating would degrade the cells would be in contact with Mg ions at 
concentrations that could increase cell proliferation and activity. 
  
 
 
 
 
 
Chapter 6 
General discussion 
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In this work, a series of surface treatments were used with the aim of controlling the 
corrosion rate and increasing the cytocompatibility of Mg-based materials. Three 
methods were used to control the corrosion rate: alloying composition, anodisation and 
polymeric coatings. Chapter 4, of this work, presented the results from in vitro direct 
assays used to evaluate the cytocompatibility of different compositions of Mg alloys, 
anodisation and polymeric-based coatings. Chapter 5 described the results from the 
indirect assay in a series of Mg-based materials previously analysed in Chapter 4. 
Naked Mg alloys, with different alloying compositions, showed a decreased 
cytocompatibility, observed in the viability/proliferation assay (MTT) and morphology. 
Mg alloys show a high corrosion rate when in contact with aqueous medium, such as 
culture medium [40]. This corrosion is accompanied with the release of hydrogen 
bubbles, increased pH and release of Mg alloy particles which have been found to 
decrease the biocompatibility of these materials [26,43]. Also, it was observed that the 3 
alloys tested (AZ61, AZ31 and RZ5) showed different degrees of cytocompatibility 
AZ61 showed the lowest cytocompatibility which could be a result from the higher 
corrosion rate observed in alloys with high concentration of Al [66,67]. It has been 
described that the composition of the Mg alloys can influence the corrosion rate and 
therefore affecting the compatibility of these materials [44,58]. 
Besides the corrosion rate on the surface of Mg alloys, other alterations in the 
surrounding environment have been described. These effects include an increase in pH 
and alteration in the concentration of important ions (Mg, Ca and PO43-) [139]. In this 
work, the incubation of AZ31 alloy in culture medium up to 24h showed an increase in 
Mg ion, from 1 mM in control medium to 21 mM in the respective extract, in the 
medium. In order to access the effect of these alterations, an indirect assay was 
performed and the results were analysed in Chapter 5. 
In the indirect assay, high concentrations of the extracts from AZ31 alloy caused a 
toxic effect in osteoblastic, osteoclastic and endothelial cells. These effects were 
characterized by a decrease in viability/proliferation and functional activity of these 
cells. These results could be linked to an alteration in the concentration of Mg ion in the 
culture medium. Cells cultured in the presence of high concentrations of Mg ions 
showed a decrease in viability proliferation (Chapter 5). This observation has been also 
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described by other authors for osteoblastic, osteoclastic and endothelial cells 
[150,151,155]. 
The results from the direct and indirect assays, in AZ31 alloy, showed that the 
cytocompatibility of the alloy is influenced by the corrosion rate [26,43], pH of the 
medium [43], concentration of ions [150,151,155] and debris. In fact, the direct assay 
might show a lower cytocompatibility due to the fact that it has a combination of the 
effects of corrosion on the surface of the materials plus the effects in the culture 
medium. 
Two of the alloys previously tested, AZ31 and RZ5, were coated by anodisation. 
This method created a coat of magnesium, oxygen, phosphorous and fluoride which has 
been described to decrease corrosion rate of Mg alloys [124]. The direct assays in both 
alloys showed an increase in viability/proliferation compared to the results in naked 
samples. The controlled corrosion rate increased the attachment of the osteoblastic cells 
to the surface of the alloys. This coating method has been described to reduce the 
hydrogen evolution hence increasing the attachment of cells to the surface [11]. 
Although anodisation leads to the reduction of hydrogen evolution, it has been 
described that it might not be able to delay the beginning of degradation [11]. An 
indication of this effect is the fact that, in this work (Chapter 3), it was observed an 
increase of Mg ion concentration in culture medium when anodised AZ31 was 
incubated for 24h; a result similar to the one observed for the naked alloy. 
The indirect tests of anodised AZ31 showed a similar result to the one observed in 
naked samples, i.e., at high concentrations a toxic effect is observed. As described in 
Chapter 5, the high concentrations of anodised extract decreased the 
viability/proliferation and the functional activity of osteoblastic, osteoclastic and 
endothelial cells. These results could be affected by the concentration of Mg ions, as 
observed in the quantification of Mg ion in these extracts showing a significant increase 
of this ion compared to control culture medium. As previously discussed, high 
concentrations of Mg ion can lead to toxic effects such has the ones observed in this 
work. Anodisation created a protection coating that limits the effects of corrosion on the 
surface but it allowed the dissolution of a high quantity of Mg ions and other debris that 
could seriously affect cells. 
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In both materials, naked and anodised AZ31 it was observed a beneficial effect at 
lower concentrations of extracts, in the indirect assays. This was possibly correlated to 
the increase of Mg ion in the culture, which was showed to have a beneficial effect such 
as increasing the viability/proliferation, functional activity and gene expression 
(Chapter 5). The same effects have been described in the literature for osteoblastic cells 
[110,111], osteoclastic cells [151] and endothelial cells [155]. These results show the 
importance that controlling the corrosion rate could have in the success of Mg-based 
implants. The release of tolerated or beneficial concentrations of Mg ions to the 
surrounding environment could lead to an increase in osteocompatibility of Mg alloys 
and further increase in bone formation. 
To achieve a better control in corrosion rate, a third method based in polymeric 
coatings was used. As described by Zomorodian et al., both polymeric coatings showed 
a decrease in corrosion rate [55,56]. In both polymeric coatings, cells were able to 
attach to the surface of the materials and further proliferate. Compared to naked and 
anodised samples, these polymeric coatings presented a better performance with a high 
proliferation rate and the morphology of the cells was closer to control cultures. In 
literature similar results were described for these coatings [89,122]. The polymeric 
coatings have been described to decrease the corrosion effects, such as release of 
hydrogen bubbles, creating a better surface for cells to attach and proliferate [11,55,56]. 
Furthermore, the use of HA particles showed an increase in viability/proliferation and 
even functional activity (Chapter 4). HA particles have been described to increase the 
functional activity and further increase the osteocompatibility of osteoblastic cells 
[136].  
A combination of treatments, anodisation and polymeric coating, was evaluated by 
an indirect assay. Firstly, incubation of the coated alloy in culture medium, for 24h, 
showed a limited release of Mg ions to the medium, evidencing the corrosion protection 
of this coating. In the indirect tests, the coated alloy showed a similar result to control 
cultures, for all the cells tested (Chapter 5). 
The results of this work showed that the decrease in corrosion rate by surface 
treatments, such as anodisation and polymeric coatings, can lead to a better cell 
attachment and proliferation. Furthermore, the controlled release of Mg ions to the 
surrounding environment could lead to a better osteocompatibility. Specific 
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concentrations of Mg ion can lead to increased viability/proliferation of osteoblastic, 
osteoclastic and endothelial cells, as observed in this work. 
In conclusion, the surface treatments analysed in this work showed promising 
results, increasing the cytocompatibility of Mg alloys. The combination of the surface 
treatments could be an interesting alternative for using Mg alloys as biodegradable 
implants in orthopaedic applications. 
 
  
 
 
 
 
 
Chapter 7 
Conclusions and Future Perspectives 
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7.1 Conclusions 
 
In this work, a series of Mg alloys and surface treatments used to control corrosion 
rate were analysed. The surface treatments performed on the Mg alloys, anodisation and 
polymeric-based coatings, resulted in enhanced biological performance. 
Firstly, three Mg alloy with different alloying compositions were tested for their 
biocompatibility: AZ31, AZ61 and RZ5 in a direct assay. From the tested alloys, AZ31 
and RZ5 showed a better biological performance, i.e. cells were able to attach to the 
substrate and proliferate. Although, for longer culture periods cells would began to 
exhibit cytotoxic effects. AZ31 alloy was also tested in an indirect assay, in which the 
extracts from the alloy were added to osteoblastic, osteoclastic and endothelial cell 
cultures. The extracts showed a cytotoxic effect common to all tested cultures at higher 
concentrations, in accordance to the direct tests. At lower concentrations, it was 
observed an enhanced differentiation of osteoblastic and osteoclastic cells, with 
increased viability/proliferation, functional activity (ALP or TRAP) and gene 
expression. It was observed an influence of the Mg ion in the results observed in the 
indirect assay. At specific concentrations, 1 mM (osteoblasts), 10 mM (osteoclasts), Mg 
ion was also able to increase viability/proliferation, functional activity and gene 
expression in these cells.  
A second approach to control corrosion rate used in this work was anodisation by 
PEO. Compared to bare alloys, anodisation was able to create a less dynamic 
environment for cell attachment and survival. In both anodised tested alloys, AZ31 and 
RZ5, cells were able to attached and proliferate. It was observed an increase in 
viability/proliferation and a normal cell morphology in both alloys. However, for longer 
periods, the anodised coating also showed evident signs of cytotoxicity. Anodised AZ31 
was also tested in an indirect assay for its biocompatibility. At higher concentrations, it 
was also observed a cytotoxic effect in all tested cells. At low concentrations, a similar 
effect to the one observed in the extract from AZ31 alloy was observed. At 10%, the 
extracts were able to increase vialibity/proliferation, functional activity (ALP or TRAP) 
and gene expression, as observed for AZ31. 
The polymeric coatings, PEI- and PCL-based coatings, were found to be the most 
efficient surface treatment to control corrosion rate, allowing cell attachment, 
110 
 
proliferation and function. Cells were able to attach and showed higher proliferation 
rates compared to bare and anodised alloys, especially at longer periods of culture. In 
the PEI coatings, it was observed a better performance in the coatings with DETA+HA+ 
nanoparticles. The coating with DETA+2%HA presented a higher viability/proliferation 
and the morphology of the cells was closer to observed in control conditions. The alloy 
coated with this composition and also anodisation was also tested in an indirect assay. 
In this assay, the various concentrations of the extract tested showed a similar effect to 
the one observed in control conditions. Both assays, showed similar results, with a 
better performance of these coatings compared to the other options tested in this work. 
PCL-based coatings showed results similar to those observed in PEI-based coatings. 
The coatings with HA nanoparticles showed an increase in viability/proliferation and 
functional activity (ALP).  
Using a combination of anodisation and polymeric coating, as with 
PEI+DETA+2%HA, a significant increase in the cytocompatibility of Mg alloys is 
expected. In a first phase, cells would attach to the polymeric coating. With the 
progressive degradation of the coating, cells would be in contact with the anodised 
layer, therefore benefiting to the presence of the released Mg ions that would enhance 
cell growth and activity. Also, with the anodisation, the base alloy would be protected 
for a longer period of time, supporting the surrounding bone and the newly formed bone 
for a longer period before being reabsorbed. 
In conclusion, the multifunctionalization approach of the Mg alloys proposed in this 
study appears to be a promising strategy to obtain biologically safe and active 
biodegradable Mg-based materials for bone tissue applications. 
 
7.2 Future Perspectives 
 
Further studies are necessary to understand the results presented in this work.  
The base alloys used in this work are not made for biomedical applications, so some 
of the alloying materials and the quantity of impurities might not be recommended to 
biomedical applications. There should be a focus in creating biomaterials with similar 
111 
 
characteristics to the ones used in this work but with more suitable characteristics for 
biomedical applications. 
Polymeric-based coatings showed a potential as Mg coatings, and the long-term 
response of cells in direct contact with the substrate, such as gene expression and 
functional activity, needs to be further explored. 
In indirect tests a few questions remain unanswered, such has the effect of pH, 
osmolality and concentration of the various corrosion materials in the effect of the 
extracts. Also, a further analyse of the various components of corrosion present in the 
extracts should be performed. 
From the results of indirect tests, the coatings used in this work also presented good 
results in endothelial cells and could be suitable candidates for other applications, such 
as in stents. 
In vivo tests should also be performed to better understand the biocompatibility of 
using the polymeric coatings and the effectiveness in controlling the rate corrosion. 
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